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SUMMARY 
 
T cells play an important role in adaptive immune response and contribute in both 
cellular and humoral defense against pathogens. The development of T cells takes 
place in a specialized organ, the thymus. Thymic microenvironment facilitates 
instruction of hematopoietic progenitor cells into thymocyte lineage, maturation of 
thymocytes to CD4 and CD8 T cells and generation of self-tolerant T cell receptor 
repertoire.  
In this study, we investigated the thymocyte intrinsic molecular players in the maturation 
of CD4 T cells and the formation of regulatory T cell (Treg) lineage. We initiated our 
study from the finding that the inclination toward Treg lineage decreases with the 
maturation of CD4 T cells. Upon microarray analysis of the gene expression between 
three CD4 thymocyte maturation stages, we selected nine candidate genes and 
addressed their roles in lentiviral gain- and loss-of-function bone marrow chimera 
experiments.  
We identified two genes that influenced Treg development in our experimental system, 
Lztfl1 and Nedd4. We demonstrated that the overexpression of Lztfl1 (leucine zipper 
transcription factor like-1) abolishes thymocyte entry into the regulatory T cell lineage. 
We evidenced this in the polyclonal repertoire and observed a tendency that this could 
hold true for the thymocyte deviation in the presence of its cognate antigen.  
Further, we evidenced that the deficiency in the second candidate gene Nedd4 (neural 
precursor cell expressed developmentally down-regulated protein 4) resulted in 
increased propensity toward Treg lineage.  
In summary, we investigated the roles of intrinsic factors in the T cell development and 
were able to show that the different CD4 T cell maturation stages carry different 
molecular signatures.  The results of this study add two molecules, Lztfl1 and Nedd4 on 
the list of factors that influence thymic regulatory T cell development. Altogether, this 
study shows that the thymocyte intrinsic factors play similarly important role as antigen-
presenting cells and cytokine microenvironment in the T cell development. 
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ZUSAMMENFASSUNG 
 
T-Zellen spielen eine wichtige Rolle in der adaptiven Immunantwort und partizipieren an 
der zellulären und humoralen Abwehr gegen Krankheitserreger. Die Entwicklung von T-
Zellen erfolgt in einem speziellen Organ, dem Thymus. Das thymische Mikromillieu 
gewährleistet eine Reifung hämatopoetischer Vorläuferzellen in T Zell-Vorstufen und 
eine weitere Differenzierung dieser Vorstufen zu CD4- und CD8-T-Zellen mit einem 
selbst-toleranten T-Zell-Rezeptor Repertoire. 
 
In dieser Studie untersuchten wir thymozyten-intrinsische Faktoren bei der Reifung von 
CD4 T-Zellen und der Bildung von regulatorischen T-Zellen (Treg-Zellen). Grundlage 
unserer Studie ist die Erkenntnis, dass die Neigung der Vorläuferzellen die Treg-
Entwicklung einzuschlagen mit der Reifung von CD4 T-Zellen progredient abnimmt. 
Nach einer Microarray-Analyse der Genexpression zwischen drei verschiedenen 
Refungsstadien CD4+ Thymozyten, wählten wir neun Kandidatengene aus und 
validierten ihre Funktionalität bei der Treg-Entwicklung mithilfe lentiviral transduzierter 
Knochenmarkschimären.   
 
Wir identifizierten zwei Gene, Lztfl1 und Nedd4, die in lentiviral transduzierten 
Knochenmarkschimären Treg-Entwicklung maßgeblich beeinflussten. In unseren 
Experimenten hinderte die Überexpression von Lztfl1 (leucin-zipper-transcriptionsfactor 
like-1) die Thymozyten am Eintritt zur Differenzierung in regulatorischen T-Zell-Linie. 
Diese Beobachtung evaluierten wir sowohl innnerhalb eines polyklonalen T Zell 
Repertoires also auch in Gegenwart eines definierten Modellantigens.  
Ferner belegen wir, dass eine Defizienz im zweiten Kandidatgen, Nedd4 (neural 
precursor cell expressed developmentally down-regulated protein 4), zu einer erhöhten 
Präferenz der Vorläufer T Zelle zum Eintritt in die Treg-Linie führt.  
 
Zusammenfassend, haben wir die Rollen von intrinsischen Faktoren bei der T-
Zellentwicklung analysiert und konnten zeigen, dass die verschiedenen CD4 T-Zell-
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Reifungsstufen unterschiedliche molekulare Signaturen tragen. Die Ergebnisse dieser 
Studie identifizieren zwei weitere Moleküle, Lztfl1 und Nedd4, als wesentliche 
Komponenten einer suffizienten Entwicklung regulatorischer T-Zellen. Insgesamt zeigt 
diese Studie, dass die thymozyten-intrinsischen Faktoren ähnlich wichtige Rolle spielen 
wie die antigen-präsentierende Zellen und Zytokin-Mikroumgebung. 
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INTRODUCTION 
 
The immune system is an essential part of multicellular organisms. It is a system 
through which each organism is able to protect itself from infection. It operates on 
several processes simultaneously in order to provide immune defense. The highly 
developed immune system is comprised of mechanisms from nonspecific chemical 
defense, such as the complement system and antimicrobial peptides to the cellular-
effector defense, such as the cytotoxic T lymphocytes, most of which are vital for 
survival. The two major branches of the immune system are the innate and adaptive 
immune systems. The innate immune system is evolutionary older and based on less 
diverse and simple recognition and defense mechanisms, while the adaptive immune 
system uses highly specific and mechanistically further developed processes [1, 2]. The 
innate immune system recognizes evolutionary conserved, pathogen-associated 
molecular patterns by utilizing germ-line encoded receptors. Although these receptors 
offer an important first line of defense and their variety provides recognition of multiple 
pathogenic structures, for complete immune surveillance in a complex multicellular 
organism, the innate immune system is not sufficient [3]. As microorganisms constantly 
improve their ability to infect a host and evade its immune system, the evolutionary 
pressure has facilitated the development of a further palette of defense strategies, like 
the adaptive immune system [2].  
The major hallmark of the adaptive immune system is its significant variability in terms 
of pathogen recognition. The adaptive immune system is based on a network of 
different lymphocyte populations, T and B cells and their major antigen-presenting cells, 
dendritic cells. Further, the unique ability of B and T cells is the recombination of defined 
genomic, germ-line encoded elements into the receptors used for pathogen recognition. 
Through this error-prone, non-homologous, end-joining process, the adoptive immune 
system generates a vast variability of receptors specific to an enormous palette of 
potential antigens. Through this diversification of germ-line encoded elements, an 
enormous number of clones with defined specificity are generated and released in the 
periphery of the organism for immune surveillance.  In addition to the flexibility of the 
generated repertoire is the ability to improve and increase specificity towards an actual 
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infecting pathogen upon successful cross talk between involved lymphocytes. 
Therefore, the adoptive immune system is an orchestrated approach, utilizing highly 
specific pathogen recognition receptors, based on professional antigen-presentation 
and multicellular cooperation to fight infection and memorize it for an efficient 
eradication in case of reoccurring infection [1, 4].  
The generation of such a vast repertoire is based on the ability of developing 
lymphocytes to rearrange V (variable) - D (diversity) - J (joining) immunoglobulin gene 
segments in a very random fashion. One important caveat in this development is the 
generation of potentially self-recognizing receptors that would have to be removed from 
the repertoire. For this scenario, evolution has built several checkpoints at the 
developmental level to secure the functionality of these rearrangements and the 
tolerance toward self [5, 6]. 
From the evolutionary point of view, the origin of somatic diversification may lay in the 
need to differ between autochthonous parts (resident or ‘self’ epotopes) and 
allochthonous parts (passenger, pathogenic, ‘nonself’) in a mutualistic system between 
two organisms, e.g. in the gut of a vertebrate which requires bacteria for vitamin 
production. Additionally, somatic hypermutation offers an efficient way to form a diverse 
repertoire without vast up-scaling of the genome [1]. 
One of the major players in the adaptive immune system is the T lymphocyte. T 
lymphocytes develop from their precursor, coming from the bone marrow into an organ, 
dedicated for T cell development, the thymus. The thymus is together with the bone 
marrow, the primary lymphatic organ that provides microenvironment for T cell 
development. The evolution of the thymus dates most likely to the evolution of VDJ 
recombination machinery, as it is only found in the species that perform these 
recombination steps, at earliest in the jawed vertebrates [7, 8].  
In the early sixties, general opinion supported by Sir Medawar was that the thymus 
playes no immunological role and that the presence of lymphocytes in this organ was 
due to an ‘evolutionary accident’ [9]. In the experiments with thymectomyzed mice, 
several researchers were able to demonstrate that this prevented lymphocytic leukemia, 
and it was further observed that mice thymectomyzed at birth lacked lymphocytes in the 
blood and all other lymphoid tissues. Furthermore, these mice seemed unhealthy and 
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showed rapid wasting [10, 11]. The first demonstration of immunological role of thymus 
was the prevention of the wasting in thymectomyzed mice by thymus transplantation 
[11]. Additionally, the insight into the tolerogenic role of the thymus was the fact that 
thymectomyzed mice did not reject the allogeneic skin transplants. Under further 
examination, it became clear that thymectomy led to only partial loss of lymphocytes 
and this introduced the idea that the immune system consists of the thymus-dependent 
and -independent branches [12-14]. 
Today we know that the thymus arises from the third pharyngeal pouch and that it is 
essential for the functional immune system as it forms a niche through which signals for 
T cell lymphopoiesis are available and where non-hematopoietic and hematopoietic 
cells communicate to keep this process ongoing [8, 15]. The scaffold of thymic stromal 
cells provide signals to the arriving progenitors to commit to the T cell lineage, guiding 
them to the rearrangement of their antigen receptors. They probe these for functionality 
and specificity to self and provide survival signals for those that pass all the checkpoints 
and are ready to exit into the periphery.  
In general, the thymus is composed mostly of developing T lymphocytes. Other 
hematopoietic cells are a few B cells, macrophages and dendritic cells. The non-
hematopoietic compartment is represented by cortical and medullary thymic epithelial 
cells (TECs) and mesenchymal cells, like fibroblasts and endothelial cells [15]. The 
morphological compartmentalization shows the outer, darker zone – the cortex and the 
inner, lighter zone – the medulla. Thymic cortical and medullary epithelial cells play 
indispensable roles in the T cell development and mirror two major checkpoints, positive 
and negative selection of developing thymocytes. The thymic stroma is far from a solely 
structural scaffold but provides signals that drive T cell development. 
T cell development  
T cells, different to other hematopoietic cells, do not develop in the bone marrow but in 
the thymus. Common-lymphoid progenitors from the blood enter the thymus and mature 
to early thymic progenitors that further develop to T cells [16, 17]. The early thymic 
precursors form a very small population with limited to absent self-renewal potential that 
gives rise to further mature T lymphocytes. Due to this, T cell lymphopoiesis is 
dependent on the recruitment of these precursors from the bone marrow [18]. This entry 
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of precursors is a gated phenomenon, involving a variety of cytokines such as CXCL12, 
CCL21 and CCL25 and several adhesion molecules P-selectin, VCAM-1, MadCAM-1, 
ICAM-1, laminin and fibronectin [19-23]. The new arrivals enter the thymus at the 
cortico-medullary junction through the high endothelial venules and are the earliest T 
cell progenitors [24, 25]. These cells at the cortico-medulary junction are known as the 
first of four so-called, double negative populations of developing thymocytes, DN1. They 
are phenotypically described as cKit+CD4-/lowCD8-CD3-CD25-CD44+ and are 
heterogeneous in their expression of CCR9, Flt3 and CD24 [26-28]. Upon their entrance 
into the thymus, DN1 cells remain at the cortico-medullary junction via CCL19/CCR7 
retention and perform up to ten cell divisions, mainly led by cKit/SCF, IL7/IL7R and 
Hedgehog signaling over Smoothened receptor [29-32]. In this region, cortical stromal 
cells express high levels of Delta-like molecules 1 and 4, (Dll1 and Dll4) which are 
essential for the signaling to the Notch1 receptor on the DN1 population and 
specification to the T cell lineage [33]. This communication is essential for the T cell 
development as experiments with inactivation of Notch1 or its downstream transcription 
factor recombination signal binding protein J (RBP-J) leads to complete abrogation of T 
cell development in favor of ectopic B cell development [34, 35]. The processes 
happening upon the Notch1/Dll1 and Dll4 interactions in DN1 cells are still unknown.  
Continuing their proliferation, T cell lineage specification and moving toward inner cortex 
DN1 cells acquire their DN2 phenotype, CD25+CD44+. This relocation is based on 
CXCL12 and CXCR4 interaction and leads cells into the region with high IL7 and SCF 
availability, which in turn further promotes proliferation and survival and most 
importantly induces the expression of Rag (recombination-activating protein) enzymes 
[36-39]. The Rag enzymes are responsible for the recombination of VDJ somatic 
segments and this is the point at which TCR rearrangement starts. Firstly, TCRγ and 
TCRδ are rearranged [40]. Interestingly, it has been shown that IL7 plays a role in the 
timey opening of the TCRγ locus upon Stat5 signaling and histone acetylation, as the 
recombination of this locus is blocked in IL7R deficient mouse [41, 42]. Continuing to 
the subcapsular zone, DN2 cells transit to the DN3 stage (CD25+CD44-), characteristic 
for ongoing TCRβ rearrangements and irreversible commitment to the T cell lineage. In 
this stage, rearrangement of TCRβ takes place in two major steps. Firstly, on both 
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alleles in parallel D-J fragment recombination takes place. Secondly, at only one allele, 
rearranged DJ fragment recombine to V fragment. The second part of the process is 
termed ‘allelic exclusion’ and reassures that the cell expresses only one in/frame 
rearranged TCRβ chain [43-45]. Subsequently, DN3 cells undergo the process of β 
selection, test of functionality for the newly rearranged TCRβ chain. For this, TCRβ 
chain couples with the invariant preTCRα chain, CD3δ, ε, γ and its successful ligand-
independent signaling results in survival of a cell and acquisition of DN4 (CD25-CD44-) / 
pre-DP stage [46-48].  
At the pre-DP stage, cells expand enormously and migrate toward the outermost 
cortical region. The expression of Rag enzymes is kept relatively low during the 
expansion phase in order to avoid any further rearrangements of preselected β chains. 
In this fashion, a pool of cells carrying functional β chains expands and generates a 
number of cells that will independently rearrange α locus and therefore enrich the 
TCRαβ repertoire [49, 50]. Upon accomplished TCR α locus recombination, cells 
acquire DP (CD4+CD8+) phenotype and start inward migration through cortex to the 
medulla, over the next two important checkpoints, the positive and negative selection.  
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Positive selection 
In the process of positive, selection heterodimeric TCRαβ molecules interact with the 
peptide / MHC molecule complexes on the cortical thymic epithelial cells. Through this 
process, the thymus ensures that the repertoire generated through primarily random 
rearrangement is useful to the host, as it is firstly restricted to the self-MHC and will be 
able to recognize peptides presented within these complexes. The binding strength of 
this interaction results in signaling over TCR to either allow the cell to survive, or if the 
newly generated TCR shows no or low ability to bind this complex, the cell will undergo 
apoptosis, in a process of ‘death by neglect’ [51, 52]. Receiving a positive signal, the 
selected cell will downregulate and repress Rag enzymes, express survival molecules 
Bcl-xL, RORγ, TCF-1 and proceed the migration toward the medulla [53-55].  
The process of positive selection was first described in the F1 bone marrow chimeras, 
in which T cells develop only if the peptide is presented on MHC molecules that are the 
same as the bone marrow recipient [56]. Further and more direct evidence was 
provided by TCR transgenic models, in which TCR transgenic T cells developed solely 
in the thymus of the same haplotype that was used to identify that particular TCR in the 
first place [57]. 
 Although the CDR1 and CDR2 loops of TCR have inherent affinity for MHC molecules, 
controlled by germline-encoded amino acids in these regions, the chance of generating 
a self-MHC-restricted TCR is very low [58-61]. Therefore, DP cells are allowed to 
rearrange TCRα locus several times in order to pass positive selection. This process is 
limited by the amount of time between three and four days that each DP cell is given to 
accomplish multiple rearrangements and pass to the medulla for the next checkpoint 
[62].  The interaction between TCR and peptide-MHC complex is driven by the contact 
of conserved amino acid residues between Vα and Vβ TCR chains and MHC helices 
[63, 64]. In this manner, the CDR3 region of TCR is positioned to interact with the 
presented peptide.  
One of the most fascinating questions in the study of positive selection is the nature of 
ligands presented on the MHC molecules. As MHC molecules present mostly self-
peptides, it is of high interest to understand how the number, origin and similarity 
between these peptides resemble the real antigen.  
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Nowadays, it is mainly contended that all positively selecting peptides derived from 
different models and described as cognate agonists, antagonists, self-antigens or 
altered peptide ligands activate different molecular networks below TCR or perform this 
activation with different quality. Therefore, one TCR can in recognition of diverse 
peptides lead to different T cell response. The TCR signaling has probably evolved to 
this complexity in order to integrate all signals percepted via single TCR and to separate 
high-affinity signals from low-affinity signals important for the development and 
homeostasis [65-70].  
The threshold of TCR/MHC interaction in the positive and negative selection has been a 
longstanding question in immunology. Today, we appreciate that the affinity of the 
peptide ligand, kinetics and location of Ca2+ and Erk signaling play a role [71, 72].  
Our understanding of how TCR threshold instructs T cells at the selection point is 
mainly based on the work using a palette of OVA peptide variants and OTI TCR in 
FTOC, performed by the Palmer lab [73].  
These experiments provided a major picture of TCR signaling involved in positive and 
negative selection. The investigators designed variants of OTI TCR agonist peptide 
(OVA variants) to define boundary between positive and negative selection and to study 
how small changes in affinity translate into cellular fate. They observed how developing 
thymocytes differ at the levels, rate and localization of CD3ζ, ZAP70, LAT and Erk 
phosphorylation upon exposure to a palette of variants (negative and positive selectors) 
with different affinities. They observed that negative selectors induced very rapid Ca2+ 
flux, and faster CD3ζ and ZAP70 phosphorylation compared to the positive selecting 
ones. Further, negative selectors induced faster LAT phosphorylation, peaking early in 
the signal transduction, while positive selectors provoked steadier phosphorylation at 
later points of interaction. Additionally, negative-selecting ligands induced 
phosphorylation of Erk at the plasma membrane, whereas in positive selection it 
happened in the cytoplasm [73]. 
CD4 versus CD8 lineage commitment 
CD4 and CD8 molecules are TCR correctors and bind to MHC II and MHC I 
respectively and exclusively. Their major role is the promotion of TCR signaling via 
recruiting of the downstream signaling molecules [74].  
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During the positive selection, cells express both TCR correctors, CD4 and CD8 to allow 
survival of all thymocyte with successfully rearranged and self-restricted TCRs. Further, 
depending on whether the selected cell has MHCI – or MHCII – restricted TCR, it will 
develop into a CD8 or CD4 SP thymocyte. Although heavily investigated, how this 
process is regulated is still a matter of debate. Firstly, two classical models were 
described: the stochastic and the instructive model. The stochastic model proposes that 
the expression of one or other corrector terminates randomly, and that, consequently, 
through a TCR/driven rescue step, only those cells left with the right corrector will 
survive [75, 76]. This model is mainly based on the experiments in which corrector 
expression is enforced or the silencing is ablated. In those models, cells with any of 
these interferences would appear in the ‘false’ population. Nevertheless, in none of 
these experiments, the ‘false commitment’ rate was about 50% of what would be 
expected by the model. Additionally, this model proposes that the positively selected 
thymocyte would be susceptible to cell death in the expectation of the second, TCR-
driven rescue step, which was not evidenced, as these corrector ‘mismatched’ 
thymocytes develop normally into mature T cells.   
Strength-of-signal instructional model provides another explanation to the lineage 
commitment problem. This model starts from the information that the cytosolic tail of 
CD4 molecule binds more Lck and would be therefore able to provide a stronger signal 
than that of the CD8 corrector [77, 78]. According to this model, the strong signal 
integrated from TCR-corrector engagements would result in CD4 lineage, while signals 
of lower strength would produce CD8 T cells. Similarly, the duration-of-signal model, 
proposes that longer TCR interactions lead to downregulation of CD8 expression and 
result in CD4 lineage commitment, while short ones terminate CD4 expression [79]. 
Although all classical models provide some insight into the commitment, they have all 
been contradicted in diverse experimental setups.   
Another model, the kinetic signaling model provides probably the best explanation to 
this phenomenon. This model postulates that the lineage commitment depends on the 
duration of the TCR signal, as sensors of duration serve the common γ chain cytokines. 
Further, the kinetic signaling model is based on the observation that positively selected 
DP thymocytes ceased their expression of CD8 but not CD4 and therefore, CD4+CD8lo 
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cells still remained lineage uncommitted. If the signals provided by engaged TCR would 
remain, while their intensity in CD8 expression deceases, that cell would commit to the 
CD4 lineage, as CD8 signaling would obviously have no impact on the ongoing process. 
On the other hand, if the signaling would lose its intensity, the T cell would re-express 
CD8 and downregulate CD4 [80, 81].  
The network of transcription factors behind this process has been a matter of study for a 
long time. One of the major components is a molecule that initiates CD8 
downregulation, ThPOK. ThPOK is also important for the complete establishment of the 
CD4 lineage [82-84]. Further, Runx3 has been described as the master regulator of 
CD8 lineage as it silences CD4 locus [85-87].  
Negative selection and immunological tolerance mechanisms 
The idea of tolerance ‘acquisition’ during the immune system development was 
introduces by the work of the Medawars laboratory in the 1953 [88]. This idea 
developed through their observations that in utero inoculations of mouse embryos with 
an autologous cell suspension, resulted in a partial or complete tolerance to following 
skin transplantation from the donor of the cell suspension to the grown up, previously 
inoculated recipient. 
The mechanisms of tolerance induction were thoroughly studied for more than twenty 
years, when the work of Kappler and Marrack offered strong evidence for the clonal 
elimination of self-reactive thymocytes [89]. In this work, T cells bearing the Vβ17a TCR 
chain were eliminated in the presence of superantigens deriving from mouse mammary 
tumor viruses presented in the context of I-E MHC molecules. Following this work, 
Palmer’s group added further evidence for clonal deletion toward contemporarily known 
self-antigens, products of Mtv-8 and Mtv-9 for deletion of Vβ5 and Vβ11 TCR clones 
[90]. Through this work the tolerance idea was based on clonal deletion, but soon it 
emerged that different mechanisms may be needed to enforce complete tolerance, as 
clonal deletion is often incomplete.  
The general knowledge of tolerance in the immune system is definitely based on the 
described work, but it has been strengthened by the discovery of two further 
phenomena – the promiscuous gene expression in the thymus and the development of 
regulatory T cells as mechanism of instructive tolerance [91-93].  
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The process of negative selection is often illustrated as the second step in the 
continuum of T cell repertoire formation. Within this step, thymic microenvironment, 
mainly by action of mTEC and dendritic cells, sorts out thymocytes with strong reactivity 
to presented self-antigens. Negative selection ensures generation of T cell repertoire 
with tolerance to self, meaning that the recognition repertoire of newly produced T cells, 
should lack all autoreactive T cells and therefore be of no potential harm to the 
organism [94]. In addition to this layer of tolerance enforcement, there are several 
regulatory mechanisms beyond the negative selection. One of these is the development 
of regulatory T cells, a process that is tightly related to the negative selection [95].  
According to the majority of the evidence, negative selection takes place mainly in the 
thymic medulla [96]. This region of thymus contains two major antigen presenting cell 
types: medullary thymic epithelial cells (mTECs) and dendritic cells. These cells both 
express higher levels of MHC molecules and in contrast to cTECs, also costimulatory 
molecules CD40, CD80 and CD86, important for negative selection [97, 98]. Further, it 
has been shown that negative selection combining strong TCR signals and 
costimulation affects semi mature T cells (CD24hi) residing in the medulla and not, fully 
developed mature (CD24lo) T cells [99, 100]. Nowadays, additional evidence from mice 
deficient in REL-B, LT-βR or TRAF6 have identified the medulla as the place of negative 
selection. These mice have defects in cortico-medullary organization, resulting in small 
or absent medulla and therefore severe autoimmunity but unaltered positive selection 
[98, 101-103]. 
From the intrinsic point of view, cortical and medullary tools for generation of presented 
peptides differ as well. cTECs are characterized by expression of a special β5t 
proteasome subunit that is incorporated into 20S proteasomes, in place of β5 or β5i 
subunits and so therefore equipped for generation of different peptide repertoire than in 
the medulla [104, 105]. Further, APCs in the medulla express high levels of cathepsin S, 
while cTECs mainly utilize cathepsin L and TSSP (thymus specific serin protease) for 
formation of MHCII class peptides [106-109]. In addition to the different enzymes 
involved, cTECs have a higher degree of autophagy than mTECs, which strongly 
impacts positive selection [110].  
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Additionally, the antigen presentation spectrum in the medulla is shaped by dendritic 
cells able to cross-present surrounding antigens and the mTECs with the prominent 
ability of promiscuous gene expression [111].  
The promiscuous gene expression is a unique characteristic of mTECs to reflect 
peripheral, tissue-restricted antigens and it is based on the expression of a transcription 
factor AIRE (autoimmune regulator) [112, 113].  
Mutations in AIRE lead to autoimmune polyendocrinopathy-candidiases-ectodermal 
dystrophy (APECED), a severe autoimmunity. AIRE has been intensively studied, yet 
still a mechanism of action in mTECs still remains unclear. It has been suggested that 
AIRE promotes ectopic expression of proteins expressed elsewhere, and that it acts as 
a proapoptotic molecule leading to mTEC death and spread of expressed antigens to 
the DCs for cross-presentation [114].  
In a very thorough study performed by the Mathis laboratory, AIRE has been described 
as interacting with several molecules from four different process groups. These were 
firstly proteins involved in nuclear transport, like exportin (XPO)1 and nucleoporin 
(NUP)93 that would mediate entrance into nucleus and secondly chromatin binding 
structures like the cohesion complex, that was proposed to be the access point for the 
initial binding. Further, they evidenced interactions with post initiation RNA polymerase 
(RNAP)II-mediated transcription machinery, composed of DNA-dependent 
proteinkinase (DNA-PK), Topoisomerase (TOP)2a and RNA- polymerase II (RNAPII), 
as well as with molecules involved in pre-mRNA processing [115]. Therefore, we have a 
picture of AIRE acting at the chromatin opening and transcription modifications levels, 
leading to noisy gene expression in mTECs and tissue-restricted antigens presentation 
to the developing thymocytes.  
Previously described differences of signaling between positive and negative selection 
indicated that negative selection provides rapid signal and induces executive 
mechanisms that lead thymocyte toward apoptosis. The process of apoptosis is the 
major mechanism to remove negatively selected cells from the thymus and it utilizes 
prominent molecules of the Bcl-2 family, Bim, Bax and Bak as well as the nuclear 
orphan steroid receptor Nur77 [116]. The deficiency in Bim or combined deficiencies of 
Bax and Bak resulted in thymocytes that are refractory to apoptosis [117-120], while 
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deficiency in Nur77 has no strong impact of the efficiency of negative selection [120]. 
This is based on the phenomenon that Nur77 binds Bcl-2, an antiapoptotic molecule 
and turns it into the proapoptotic. However, in the absence of Nur77, the action of Bim 
and others is not affected. In one recent study, the expression of molecules Ian1 and 
Lip1 have been described as increasing and decreasing, respectively, with clonal 
deletion [116, 121]. Still, the exact role of these molecules remains unclear. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: T cell development in the thymus. Upon enetering the thymus at the cortico-medullary 
junction, T cell precursors undergo lineage commtiment, β-selection and positive selection in the cortex. 
In the medulla, negative selection and final maturation of single positive thymocytes occurs. 
 
 
The process of negative selection (recessive tolerance) and development of regulatory 
T cells (dominant tolerance) are two thymus-dependent processes of tolerance 
establishment, both based on high-affinity interactions between TCR and peptide-MHC 
but with two different outcomes for a thymocyte involved in TCR assessment [122].  
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The importance of this dominant branch of tolerance emerged from the experiments 
showing that thymectomy between day 2 and 4 upon birth leads to autoimmunity [123, 
124]. The link between the CD4+CD25+ population and the thymus was demonstrated 
by the work of the Sakaguchi laboratory as they observed suppression of autoimmunity 
only in the transfer of whole splenocytes or the transfer of CD4+CD25- splenocytes 
accompanied with CD4+CD25+ thymocytes, additionally distinguishing these cells from 
the temporarily activated T cells [125]. The generation of these and the recognition of a 
cognate antigen in the thymus was later linked by experiments using TCR transgenic 
models and models expressing cognate antigen in the thymus, preferentially in the 
mTECs [126-128]. One of very prominent models is TCR-HA (hemagglutinin (HA) - 
specific TCR) crossed to the Aire-HA model. The work on this model provided some 
crucial evidence that the generation of regulatory T cells (Treg) is based on the 
recognition of a cognate antigen and goes along with the negative selection [129, 130]. 
In the following experiments, utilizing AIRE-driven CIITA knockdown, and therefore 
lower expression of a cognate antigen on MHCII molecules in the medulla, it could be 
shown that the quantity of the presented antigen decreases negative selection and 
drives Treg development for several tested TCR specificities. This data show that the 
instructive phase of Treg development is certainly based on avidity of TCR/peptide 
MHC interaction and relates this interaction to the proximity of negative selection 
threshold [131].  
According to the ‘two-step-model’ of Treg development, the instructive phase is followed 
by the consolidation phase, driven by common γ-chain cytokines (IL-2, -7 and -15) and 
needed to establish a fully mature regulatory phenotype, mainly defined and 
underpinned by Foxp3 expression [132].   
Foxp3, forkhead box protein 3, is contemporarily considered as a master regulator of 
Treg lineage and a major marker of this population [133-136]. Mutation in the Foxp3 
gene in humans results in development of a severe multiorgan autoimmunity, IPEX 
syndrome (immune-dysregulation, polyendocrionopathy, entheropathy and X-linked 
syndrome). Also, mice with mutated Foxp3 gene (scurfy mice) develop lethal 
autoimmunity [137]. The seminal work of Hori and Sakaguchi shows that the 
development and suppressive function of Tregs is based on Foxp3 expression and that 
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the retroviral expression of Foxp3 is sufficient to drive naïve cells into the regulatory 
lineage, transferring their suppressive functions. Further, they characterized these cells 
for their expression of CTLA4, GITR and CD103 accompanying the CD25 expression 
and altogether demonstrated that Foxp3 develops a molecular program that is 
responsible for the suppressive capacity of these cells [133]. The following work on 
genome-wide actions of Foxp3 puts this molecule in both roles of an activator and 
repressor of gene expression and therefore, it remains considered as a central 
molecular leader of regulatory T cell lineage [138]. Therefore the aspects of Treg 
development should all lead to the stable Foxp3 expression.  
The Foxp3 promoter is epigenetically controlled by the SUMO E3 ligase, PIAS1 that 
recruits DNA methyltransferases and chromatin modeling proteins, like heterochromatin 
protein 1 (HP1) in order to keep the promoter repressed for transcription initiation [139]. 
The exact interplay needed to accompany TCR strength involved in displacement of 
PIAS1 from the promoter is unknown but mice lacking this E3 ligase show increased 
Treg populations.  
Further, the regulatory elements of Foxp3 locus have been extensively studied and the 
major three sites have been described – conserved non-coding sequence 1, 2 and 3 
(CNS1,2 and 3) [140].  
The data collected mainly describes occupation of these elements by diverse 
transcription factors and regulatory molecules in the context of TCR engagement and 
cytokine instruction. Therefore, upon defined TCR/CD28 occupation, signaling over 
PKCΘ and CBM complex towards IKK results in recruitment of c-Rel toward promoter 
region and CNS2 and 3 [141-144]. CNS3 is considered as a pioneer element, which 
probably coordinates the initial Foxp3 expression. Further, NFAT and AP1 potentially 
lead to increased cytokine responsiveness and CD25 upregulation. IL-2 and its STAT5 
signals further establish, synergize and follow recruitment of CREB, Ets-1 and Runx to 
an important CNS2 element [140, 145-147]. The demethylation of several CpG motifs in 
this Treg-specific-demethylated-region (TSDR) results in sustained and stable 
expression of Foxp3 [148-150]. The partial demethylation of this region is observed in 
peripherally induced Tregs as well as the occupation of CNS1 via Smad2/3 resulting 
from the TGFβ presence [151-153].  In sum, a coordinated interplay of signals over TCR 
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and cytokines provided in the defined environment (‘niche’) determines and influences 
the development of a regulatory T cell for a potentially harmful, self-reactive thymocyte. 
This interplay presents one of the most fascinating stages of immune system 
evolvement, the development of instructive tolerance. 
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AIM OF THE STUDY 
 
The development and maturation of T cells takes place in the thymus. This educational 
process includes the commitment of progenitor cells into the T cell lineage and the 
shaping of a useful and self-tolerant T cell repertoire through positive and negative 
selection. In addition, this process includes formation of the regulatory T cell population 
as the mediator of dominant tolerance. At each of these steps, a coordinated interplay 
between T-cell-receptor signals, antigen peptides presented in the particular thymic 
microenvironment and cytokines shapes the outcome of thymocyte education.  
From previous work on the differentiation of thymocytes, we know that the CD4 single 
positive compartment represents a diverse population of continually maturing cells. 
Consecutive stages of maturing CD4 SP thymocytes have been shown to exhibit a 
decreasing propensity toward entering the regulatory T cell lineage with advancing age. 
The aim of this study was to identify intrinsic molecular players that distinguish the 
consecutive maturation stages of the CD4 SP compartment and thus potentially 
determine the plasticity of each stage. To do so, we utilized gene expression profiling of 
these stages accompanied by data verification in real-time polymerase chain reactions. 
Further, we performed experiments based on lentiviral gain- and loss-of-function 
specifically in CD4 T cells to functionally validate particular candidate genes. In the final 
part, we explored the role of one selected candidate in the immune system and 
particularly in T cells, through conditional knockout.   
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MATERIAL AND METHODS 
Animals  
Mice were bred in the animal facility of the Institute for Immunology of the LMU Munich 
in individually ventilated cages. TCR-HA, AIRE-HA, OTII, RipmOVA, Foxp3-GFP and 
Foxp3-huCD2 mice have been previously described [129, 134, 154-157]. Nedd4fl/fl  mice 
were kindly provided by Dr. Hitoshi Kawabe [158]. Vav- and CD4-CRE mice were kind 
gift of Dr. Marc Schmidt-Supprian, Lck-CRE of Prof. Dr. Meinrad Busslinger and Foxp3-
CRE of Prof. Dr. Alexander Rudensky. Local law regulation authorities approved all 
animal experiments. 
Antibodies and reagents for flow cytometry
 
 
Specificity  Conjugate Clone Supplier 
B220 PerCP RA3-6B2 
Becton, Dickinson & 
Co. (BD), Franklin 
Lakes, NJ, USA  
CD3 APC 145-2C11 BD  
CD4 V450/ Pacific Blue GK1.5 BD  
CD8 PerCP / APC-Cy7 53-6.7 BD  
CD24 Pacific Blue M1/69 BD 
CD25 PE-Cy7 PC61 BD 
CD44 APC-Cy7 IM7.8.1 BD  
CD45.1 APC / FITC A20 
eBioscience, San 
Diego, CA, USA 
CD45.2 Pacific Blue / APC 53-6.7 eBioscience 
CD62L FITC Mel-14 BD 
CD69 PE-Cy7 H1.2F3 BD 
CD177 FITC /APC 2B8 BD 
CD127 PE SB/199 BD 
CTLA4 PE UC10-4B9 BD 
GITR PE / PE-Cy7 DTA-1 BD 
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Foxp3 PE /APC FJK-16s eBioscience 
TCRγδ Biotin GL3 eBioscience 
TCRβ APC H57-597 eBioscience 
Cd1 Tetramer PE PBS-57 Gift from C. Vahl 
NK1.1 Biotin PK136 BD 
Qa-2 Biotin 1-1-2 BD 
6C10 IgM  Gift from J. Lui  
IgM PE RMM-1 house 
Ki67 PE B56 BD 
Annexin V PE  BD 
7AAD   BD 
CD122 PE TM-b1 eBioscience 
TCR-HA APC 6.5 house 
Vα2 FITC/PE B20.1 eBioscience 
Vα3.2 FITC/PE RR7-16 eBioscience 
Vα8.3 FITC/PE B21.14 eBioscience 
Vα11 FITC/PE RR8-1 eBioscience 
Vβ2 FITC/PE B20.6 eBioscience 
Vβ3 FITC/PE KJ25 eBioscience 
Vβ4 FITC/PE KT4 eBioscience 
Vβ5.1 FITC/PE MR9-4 eBioscience 
Vβ6 FITC/PE RR4-7 eBioscience 
Vβ7 FITC/PE TR310 eBioscience 
Vβ8.1 FITC/PE MR5-2 eBioscience 
Vβ8.3 FITC/PE 1B3.3 eBioscience 
Vβ10 FITC/PE B21.5 eBioscience 
Vβ11 FITC/PE RR3-15 eBioscience 
Vβ12 FITC/PE MR11-1 eBioscience 
Vβ13 FITC/PE MR12-3 eBioscience 
Vβ14 FITC/PE 14-2 eBioscience 
Vβ17 FITC/PE KJ23 eBioscience 
Streptavidin Pacific Blue/APC  eBioscience 
 
Table 1: List of antibodies used in this study – All antibodies and reagents are listed with the 
respective clone and conjugated fluorophore. 
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Flow cytometric analysis  
FACS staining was accomplished according to standard procedures at a density of 1 × 
106 to 5 × 106 cells per 100µl. Ki67, 7AAD and Annexin-V stainings were performed 
according to the manufacturer’s protocol. Intracellular staining was performed also 
according to manufacturer’s instruction of a Foxp3 staining kit from eBioscience. 
FACSCanto Cytometer (BD) with FACSDiva software (BD) was used for data 
acquisition and recording. FACS data analysis was performed using FlowJo software 
(Tree Star Inc.).  
 
Genotyping  
For genotyping, a mouse-tail or ear pieces were digested in 50 µl of digestion buffer for 
5 hours at 55°C, followed by Proteinase K heat-inactivation at 95°C for 5 minutes.  
 
 
 
 
 
 
 
 
 
 
For genotyping polymerase chain reactions 1 µl of 50 µl digestion mix was used as 
templated DNA 
 
 
 
 
 
 
Digestion reaction  
3mm mouse tail  
3µl Proteinase K (10mg/ml 
stock)  
2.5µl Triton (10% Stock)  
5µl Gitocher Buffer (10x)  
0.5µl β-Mercapto-ethanol  
39µl H2O  
 
Gitocher buffer (10x)  
670mM Tris pH 8.8  
166mM ammonium sulfate  
65mM MgCl2  
0.1% Gelatin  
 
PCR reaction  
1µl template  
250nM primers (final)  
200µM dNTP (final)  
PCR Buffer (1x final)  
Taq Polymerase  
Ad 30µl with H2O 
PCR Buffer (5x)  
250mM KCl  
50mM Tris pH 8.3  
43% Glycerol  
7.5mM MgCl2  
2mM Cresol Red  
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A PCR programme was designed to be applicable to diverse genotyping reactions and 
was as following,  
 
Temperature (°C) duration (s) 
cyclcy
cles 
94 180  
94 45 2 
60 45  
72 60  
94 45 2 
58 45  
72 60  
94 45 2 
56 45  
72 60  
94 45 2 
54 45  
72 60  
72 300  
 
Tbl. 2: PCR protocol used for genotyping reactions.  
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For the genotyping reactions following primers were used.  
 
Genotype  Sequence 5' - 3' Amplicon 
TCR-HA fwd ACAAGGTGGCAGTAACAGGA 800bp 
  rev ACAGTCAGTCTGGTTCCTGA   
Aire-HA fwd ACAGCCACTCCTGTCTTTGC 1300bp 
  rev CTCCGTCAGCCATAGCAAATTTCT   
OTII fwd GCTGCTGCACAGACCTACT  160bp 
  rev CAGCTCACCTAACACGAGGA   
RipmOVA fwd CAAGCACATCGCAACCA 475bp 
  rev GCAATTGCCTTGTCAGCAT   
Foxp3 GFP fwd AGACAGACCAGAGGTGTAGT 
200bp 
WT 
  rev TCCTGGGGATGGGCCAAGGGCCAAGG 800bp KI 
Foxp3 
huCD2 fwd TCTCAGACTCAGGATGACTGT 
800 bp 
WT 
 int GGCTTCGGCCAGTAACGTTA 560bp KI 
  rev ATTGCTTGAGGCTGCGTATGA   
Nedd4 fwd GTACATTTTAGTTCATGGTTCTCACAGG 
200bp 
WT 
  rev CAGAGGTCACATGGCTGTGGG 300bp fl 
CRE fwd GACAGGCAGGCCTTCTCTGAA  500bp  
  rev CTTCTCCACACCAGCTGTGGA    
 
Tbl. 3: List of primers used for genotyping PCRs –Forward and reverse primers with the resulting 
amplicon size are listed. 
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Purification of CD4 T cells - Magnetic cell sorting (MACS) and Flourescence-associated 
cell sorting (FACS)  
 
Magnetic cell sorting (MACS, Miltenyi Biotec) is a technique for isolation of various cell 
types according to the expression of diverse extracellular markers based on their 
expression of different antigens on the cell surface.  
 
CD4 SP cells were purified by the staining of thymocyte cell suspensions with 
biotinylated-anti-CD8 antibody, followed by incubation of cells with streptavidin coated - 
microbeads (Miltenyi Biotech) and depletion of CD8+ and DP cells using magnetic 
columns columns, LS-MACS (Miltenyi Biotech). 20µl of MACS Microbeads in total of 
200µl of MACS Buffer were routinely used for 108 cells. The obtained CD4+CD8- fraction 
was stained for the surface markers of interest, like 6C10, CD69 etc. and further 
subdivided by FACS on FACSAria cell sorter (BD). 
 
Peripheral CD4 T cells were obtained by the staining of splenocytes and lymph node 
cells with biotinylated anti-CD4 antibody, followed by incubation of cells with streptavidin 
Microbeads in order to enrich the suspension for CD4+ fraction. The enriched 
suspensions were further stained and sorted on FACSAria (cell sorter (BD).   
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Cloning 
 
Plasmids containing CD4 regulatory elements were kindly provided by Dr. David 
Klatzmann and Dr. Ishiro Taniuchi. The laboratory of Prof. Dr. Brocker at the Institute for 
Immunology, LMU provided plasmids containing lentiviral vector backbone and all other 
plasmids used for intermediate cloning steps. Restriction enzymes were purchased from 
Roche (Mannheim, Germany) or NEB (Munich, Germany) and used at 10U / ≤1µg DNA 
at designated temperature for approximate 1h digestion reactions. Cut vectors or inserts 
were purified on a 1.5 % agarose gel and purified usinga  gel extraction kit (Quiagen, 
Hilden Germany). Ligation was performed using T4 DNA Ligase (Roche, Mannheim 
Germany) upon vector dephosphorylation by alkaline phosphatase (Roche, Mannheim 
Germany) using equal stoechiometric amounts of insert and vector. All ligation reactions 
were heat-shock (20 min on ice followed by 2min at 42°C) transfected in E.coli (DH5α) 
and plated out on LB-agar plates containing an appropriate antibiotic. Ampicillin 
(300µg/ml) and kanamycin (50µg/ml) were used as selection markers.  
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Cloning of lentiviral constructs 
 
Genes of interest were amplified on whole thymocyte genomic DNA by PCR using the 
following primer pairs:  
 
Gene of 
interest 
Primers  
Lztfl1 
forw GGGCCCATGGCAGAGTTGGGC 
 
rev CTCGAGGAATTCTTAATCTTCAGATTCATATTTTGC 
Slfn1 
forw GGGCCCATGAACATCACCGATGAAG 
 
rev CTCGAGGAATTC CTAAGACATGAGGAGCTTGAT 
Smpdl3a 
forw GGGCCCGCCACCATGGCGTTGCTGGGCA   
!
rev CTCGAGTTATAAATGCTGTTTAAGGCAA 
Ms4a6c 
forw GGGCCCATGATTCCACAGGTAGTGACC 
!
rev TACTCGAGGAATTCTCACATTCTAAGGGAAGTCAGA 
Ifi27a2l 
forw GGGCCCATGTTGGGAACACTGTTTG 
!
rev TACTCGAGGAATTC TCAGAGCAAGGCTCCA 
 
Tbl. 4: List of primers used for amplification of all genes of interest from the thymocyte cDNA –
Forward and reverse primers for each selected candidate are listed. 
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PCR products were cut using the following enzyme combinations and ligated into 
fluorescent-protein- and linker(T2a)-carring plasmids. In this way a cassette carring 
fluorescent protein, linker T2a and gene of interest was created for insertion into the 
lentiviral vector.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Scheme of lentiviral vector – Important sites: CD4 regulatory elements, eGFP reporter gene 
bridged to the gene of interest over a T2a linker and inserted into lentiviral backbone over AgeI and EcoRI 
sites.  
 
Cloning of lentiviral vectors for gene knockdown 
 
Short hairpins were designed using the software RNAi Oligo Retriever 
(http://katahdin.cshl.org:9331/homepage/siRNA/RNAi.cgi?type=shRNA) .  The murine 
stem cell virus (MSCV)-based LMP vector was purchased from OpenBiosystems and 
provided the flanking sequences of the human miR30, endogenously and ubiquitously 
expressed miRNA. The knock-down of the gene of interest is obtained through the 
exchange of miR30 sequence with the sequence of artificial short hairpin. We 
subcloned this regions in the 3’ UTR of the eGFP sequence in the lentiviral vectors. 
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 293FT cells in lentivirus production  
 
Transient transfection of 293FT cells was performed for the lentivirus production over 
three days. 2x106 cells were plated in 10 cm Petri dishes and left to grow up to 75% 
comfluence. At that point, a mixture of 10µg GOI DNA with 8µg pax2 DNA and 8µg 
VSVg DNA in 0,5 M CaCl2 in HEBS per Petri dish was added to the cells and left for 
incubation and uptake over 12-24h. After that, cells were supplied with medium and the 
supernatant was collected at 24, 48 and 72h upon transfection, pooled and centrifuged 
at 14000 rpm for 4h to obtain concentrated preparations of virus. 
Transduction of NIH3T3 cells for lentivirus titration 
 
NIH3T3 cells were plated out at the concentration of 3x104 cells/well in 24-well plates 
and left over night. A total of 6 wells were prepared for one virus titration. From each 
virus stock produced 100µl were used for titration, starting from the first well and titrating 
down in 1:3 steps over the next 5 wells. Upon 3 days, expression of GFP as the 
infection marker was used as the parameter on infection efficiency. The amount of virus 
per µl needed for full infection is then estimated by proportion of infected cells relative to 
volume of virus used. 
Bone marrow infection and chimeras 
 
Bone marrow was obtained from donor mice as femur and tibia were isolated, shortly 
placed in 80% ethanol and following in PBS. Using a 1 ml syringe bone marrow was 
flushed out in PBS, filtered and washed. Further, red cell lysis was performed using BD 
Cell lysis buffer. Donor T cells were depleted by using biotinylated anti-CD4 and anti-
CD8 antibodies and streptavidin MACS beads (Miltenyi) according to the manufacturer's 
protocol.  
For further use bone marrow was plated out at 3x106 cells / infection or intra-venously 
injected into lethally irradiated mice at 1-3x106 cells / mouse. BALB/c mice were 
irradiated with 2x450rad and C57-BL6/c with 2x550rad respectively.  
Infection was performed in Stemline medium (Sigma) supplemented with IL3, IL7 and 
SCF  (R&D Systems, Wiesbaden, Germany) with 10 µg/ml Polyprene and multiplicity of 
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infection (MOI) of 1 for 6-8 h.  After infection, cells were washed and rested in cytokine-
supplemented Stemline medium (Sigma Aldrich, Taufkirchen, Germany) for 2 days.  
Chimeras were analyzed 6-8 weeks after reconstitution.  
 
RNA Isolation and real time PCR 
 
Total RNA was isolated using the miRNeasy Kit (Roche, Mannheim Germany) and used 
for cDNA synthesis by iScript™ cDNA Synthesis Kit (BioRad), both steps conducted 
according to manufacturer's protocol. Quantification of mRNA expression was carried 
out using SsoFast™ EvaGreen® Supermix on  C1000™ BioRad cycler. 
Calculation of gene expression levels was carried out by using following formula: 
 
Relative expression = 2-ΔΔCt 
Ct values represent the threshold cycle for each transcript detected and ΔCt represents 
the difference between the threshold cycle for a gene of interest and the housekeeping 
gene, β-actin. ΔΔCt values relate the ΔCt differences between the examined populations 
and the population used for normalization (mainly SP1).  
 
Program used for real time PCR: 
 
Temperature (°C) Duration (s) Cycles 
94 300  
94 45 40 
56 40  
72 60  
72 60  
Tbl. 5: Protocol used for the real time PCR reactions. 
 
Melting curves for each reaction were analysed between 55° and 95°C with the range 
on 0.5°C / 30 s.  
                                                                                                                                                               Material and methods 
34 
Following primers were used for the verification of the microarray data obtained:  
Gene sequence fwd sequence rev 
amplicon 
size (bp)  
intron 
spanning 
Rorgt ACAGGGTCCAGACAGCC CACCTCCTCCCGTGAAA 181 yes 
Eef1a1  GTGCTAATATGCCTTGGTT CTTGTCAGTTGGACGAGTT 119 yes 
Itm2a AGATCGCCTTCAACACC TCCTGCGGGACAACTC 127 yes 
Lef1 CTTCGCCGAGATCAGTCA CTGGCCTTGTCGTGGTAG 153 yes 
Ube2d3 ATGGCAGCATTTGTCTTG GGTCGTCTGGGTTTGG 111 yes 
Fubp1 TGGTGCTGATAAACCTCTT CCCTTCATTGCCTCCTA 145 yes 
Dub2a ACAGACAATCAGAACCCAC CCTGGCAATGGAGACA 96 no 
Fyn GCTCGGAAGGAGACTGG CTCGCGGATAAGAAAGGTA 191 yes 
Tspan13 TGAGGTTTGTTGGTGGCA GCGAGGGTCTTTCTGGTT 95 yes 
Pbrm1 CAGGAGGCTATCCAGTAA AGGTCCATTGGCTCTAA 177 yes 
Samhd1 TTCACCAAGCCACAGG AACTAACCGCAGATATTCA 140 yes 
Ccr9 AGCACAAGGCCCTCAA TGGCATAAGCGTCAACA 105 no 
Cbx3 TGCTGCTGACAAACCA TTCATGTTCGCCTCCT 150 yes 
Cd28 AGGCTGCTGTTCTTGGC GGCTGACCTCGTTGCTAT 106 yes 
Nr4a1 CCTGGCATACCGATCTAAAC AGGCGGGAACATCAACAC 158 yes 
Hcls1 GCATGATGTATCGGTTTCC CAATGGTCTTGGCTCCC 110 yes 
Tm9sf3 TACTTCATCTTCACGTCCTT TCGTCCACTGCCACCT 157 yes 
Lztfl1 CGGTAGATTCCTGCTT TCGGACTCCACCTCAC 124 yes 
Rab1 AGTCCTGCCTTCTCCTT CTTTCCTGGCCTGCT 145 yes 
Wsb1 TCCCAGTGCCGTAAGA TGCTCAGGAGGCTTGTT 116 yes 
Ppp2r5c AGTCCCTGAGTGTCTACCA TTGAGAAGTGCCATTACC 100 yes 
Lsp1 GCCGTAGCCAGTACCAA TCCTTTCTGCTCCCACA 129 yes 
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Tbl. 6: List of primers used for RT-PCR analyses –Forward and reverse primers with the resulting amplicon size are listed. For each gene we 
tended to design RT-PCR reactions that would cross exon-exon junction and therefore increase the specificity of reaction. 
Zfp445 TCGGTGCCTGACTATTT AGAGCAGGTTTGGGAGA 197 yes 
Foxo3 AAACGGCTCACTTTGTCCCA TTGCCCGTGCCTTCATTC 164 yes 
Bcl2l11 CGGAGACGAGTTCAACGA ATACCAGACGGAAGATAAAGC 119 yes 
Zfp330 GCCTTGCTATGGTGGG CTGCATCTGTGAGTGGG 105 yes 
Egr2 GACCAGATGAACGGAGTG GAGATGGGAGCGAAGC 104 yes 
Olfr767 CTGGATTCGCACCTTC CTCTTGTTTCCCGTTGT 122 no 
Slfn1 CCAGGCGATGATACGC TGGCAAAGGCAGAAAC 193 no 
S100a11 CGGGAAGGATGGAAAC GGTCAAGGACACCAGGAT 110 yes 
Il6ra CCTTGCTGGTGGATGTTC CGTTGGTGGTGTTGATTTT 153 yes 
Lgals1 CGGGAGCATCACAGAGG CATGTTGAGGCGGTTGG 100 yes 
Pde3b GAATTGATGGCTTTGTATGTG AAGGAGGAAGTTGTACTCTGG 189 yes 
Ppp1r2  ATCGTGGAAGAGGAACTGA AAGCCATAGTCTTTGTCAGC 92 yes 
Naip3 TGAGCAGCATCATCCA CAGGTCCGTGACAAGTAG 124 no 
Zbtb16 GCCACCTTCGCTCACAT  CCTGTAGTGCGTCTCCAAC  179 yes 
Satb1  CATCCAGGTTGGGAAGTG TGCGACCATTGTTCAGG 165 yes 
Rap1a  GAAGATGAACGGGTAGTTG TCAGAGCTGCTGCTGAC 219 yes 
Rac2  TGTGATGGTGGACAGTAAGC CCACTTGGCACGGACAT 163 yes 
Ifi27l2a  GTTGGGAACACTGTTTGG GCAACTCCACCTCCATT 162 yes 
Nedd4  GCTGAACTCTATGGCTCG GCGATTGAAGCAGGTGT 96 yes 
Ms4a6c  TTGGTCTGGCTTTGC TTCCACATTGGCTTCA 110 yes 
Tbrg3  ACCCTTGTTCATCTCA ATAGTAAAAGGCGAAAG 130 no 
Smpdl3a  GCTGTGGCTGACCTCT  GCTGGGTCTGTCTTGTT  173 yes 
Dub2a 2 TGCCCAGATCCATAGCAAAT GCCCAGTGTTCACAAGGT 108 no 
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Microarray analysis 
Gene expression profiling was performed on Affymetrix Mouse Gene 1.0 ST arrays. 
RNA from sorted populations, SP1, 2 and SP3 was isolated with the miRNAeasy kit 
(Qiagen) and labeled with the WT Expression kit (Affymetrix). Raw data obtained were 
analyzed with the programs R and Bioconductor by collaborating bioinformaticians. 
Arrays were assessed for quality and were normalized by the robust multi-array average 
method. Differences in gene expression were extracted with an empirical Bayes 
moderated t-test implemented in the Bioconductor package Linear Models for 
Microarray Data. False-discovery rate was utilized for sorting the results that were 
subsequently exported in tab-delimited format [159, 160]. 
Statistical analysis 
Statistical significance was assessed by the two-tailed Student`s t-test.
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RESULTS 
Gene expression profiling of CD4 single positive thymocytes 
Upon positive selection, developing thymocytes proceed from the cortex to the medulla 
and take part in the second step of thymic education by moving through the medullary 
microenvironment and interacting with diverse antigen-presenting cells. 
Instructions received in the medulla have a strong impact on thymocyte fate and are 
considered to be a major tool of central tolerance to sort out potentially harmful cells 
from the repertoire.  In the most simplistic model, the interactions between antigen - 
presenting cells and thymocytes result in instruction of thymocyte toward survival, 
apoptosis or Treg development by the antigen-presenting cell.  
Throughout the next five to ten days [161] that a thymocyte spends moving in the 
medulla, its developmental status may change considerably and influence the decisions 
that are taken at the moment of interaction with antigen - presenting cells.  
Adding the parameter of time that a thymocyte spends in the medulla for screening 
many different antigen-presenting cells and by entering multiple interactions, we 
questioned as to whether the decisions are only made by the antigen-presenting cells or 
if there are potential thymocyte-intrinsic factors that influences these decisions.  
 
Composition of thymocyte CD4 SP compartment 
In order to address the diversity in the CD4 SP compartment, we searched for the 
earliest thymocyte that leaves the positive selection and for the consecutive maturation 
stages that compose the total CD4 SP compartment. Through intrathymic transfer of 
single populations and analysis of emerging progeny, Jin et al. provided evidence that 
these described stages are consecutive and that they emerge from a unidirectional 
precursor-to-progeny developmental line [162]. We hypothesized that these stages may 
differ in their gene expression profile and were interested in studying these potentially 
different molecular signatures in order to understand how thymocyte intrinsic factors 
influence formation of central tolerance. For these studies, we identified three 
populations by utilizing maturation markers CD69, CD24, and maturation-dependent 
glycosylation changes of CD90.  
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CD69, a TCR-stimulation-dependent activation marker, is highly expressed on the 
double positive thymocytes undergoing positive selection and on the small population of 
CD4SP that have recently been positively selected [163]. Its blockade by monoclonal 
antibodies leads to dysregulation of selection process and dramatic loss of SP 
compartments [164]. 
Further, we used the antibody SM6C10 to distinguish between two subpopulations of 
CD69+ SP thymocytes [165]. SM6C10 recognizes a surface carbohydrate epitope of the 
CD90 molecule. CD90 is ubiquitously expressed on thymocytes and represents their 
major glycoprotein [166]. The levels of the 6C10 epitope decrease with the ‘age’ of a 
thymocyte [165]. 
Lastly, we used CD24 (HSA, heat-stable antigen) to separate and confirm age of the 
thymocytes used in the analyses. CD24 is highly expressed on immature thymocytes 
and declines with maturation [167, 168].   
The three SP populations that are the focus of the study were named SP 1, 2 and 3, 
from the youngest to the oldest ones. 
 
 
Fig. 3: Dissection of CD4 SP maturation stages and gating strategy for SP 1, 2 and 3 sorting. The 
plots depict stainings of thymus of Foxp3-GFP reporter mouse for markers used for SP1,2 and 3 sorting. 
Numbers in the plots indicate frequencies of cells within the sorting gates. Histograms show overlays of 
CD24 expression on SP 1,2 and 3 subpopulations.   
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Microarray analysis of CD4 SP stages and candidate selection 
In order to gain insight into the molecular signature of these different consecutive stages 
(SP1, 2 and 3), we performed gene expression profiling.  
Upon filtering microarray data by defining a 2-fold-change cut-off we obtained a list of 
45 differentially expressed genes between three various subsets. Tables 7.1 and 8.1 
sum up the results of gene array analysis. In the following Tables 7.2 and 8.2, we listed 
the differentially expressed genes and their described functions resulting from the 
general and T cell-related literature research. Further, these tables summarize selection 
criteria, which we used for each selected candidate. Tables 7.3 and 8.3. present the 
overview of gain-of-function (GOF) and loss-of-function (LOF) experiments that were 
undertaken for the selected candidates. For most of the candidates we performed a 
verification real-time PCR analysis before we narrowed down the candidate selection 
(Fig 4.).  
Interestingly, all the expression differences emerging from the microarray analysis have 
in common that the gene expression maintains its directionality over the stages. For 
example, genes are either up- or down-regulated from SP1, 2 to 3, and there are no 
genes with a relative peak or minimum of expression at the SP2 stage. This observation 
is consistent with the intrinsic developmental relationship between the stages. 
 
In general, the first selection was based on the genes that showed the highest 
differential expression (Dub2a and Itm2a). Further, we narrowed the selection down to 
those that were not extensively described in the thymocyte biology (Slfn1, Il6ra and 
Nedd4). One molecule was predicted to have transcription factor properties (Lztfl1) and 
was therefore included in the selection. Finally, we considered those genes interesting 
that had no described function at all (Smpdl3a, Ms4a6c, Ifi27l2a). In one previous study 
on the transcriptome of regulatory T cells, two molecules (Smpdl3a and Ms4a6c) were 
also described. This study by Gavin et al., utilized a model of in-frame insertion of GFP 
into a stop-codon-disrupted Foxp3 locus to genetically mark cells that were actively 
transcribing Foxp3 gene but had no Foxp3 protein. Through the comparison of these 
cells with the regulatory cells carrying the wild type Foxp3 locus they were able to 
characterize the Foxp3-driven transcriptional program and describe groups of Foxp3-
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dependent and Foxp3-amplified genes. According to this study, Smpdl3a was in the 
group of ‘Foxp3-amplified’ genes, while Ms4a6c was among the ‘Foxp3-dependent’ 
genes [135].  
 
In sum, we selected four genes from the group with decreasing expression during 
maturation (Dub2a, Itm2a, Lztfl1 and Nedd4) and five with increasing expression (Il6ra, 
Ifi27l2a, Ms4a6c, Slfn1 and Smpdl3a) for further analyses.  
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Tbl. 7.1: List of 28 genes with declining expression between the maturation stages. Ratio between SP1 and SP3 of ≥ 2 was set as a cut-off 
and genes are listed according to the decreasing ratio. Full gene names are listed. 
  Gene Accession Gene 
Symbol 
SP1 SP2 SP3 SP1/3 
Ratio 
Gene Description 
  NM_001001559  Dub2a  195,019 87,971 4,018 48,538 Deubiquitinating enzyme 2a  
  NM_009913  Ccr9  139,236 24,873 5,557 25,055 Chemokine (C-C motif) receptor 9  
  NM_008409  Itm2a  474,850 155,932 50,903 9,329 Integral membrane protein 2A  
  NM_033322  Lztfl1  79,732 34,367 9,723 8,201 Leucine zipper transcription factor-like 1  
  NM_007624  Cbx3  125,961 82,897 30,698 4,103 Chromobox homolog 3 (Drosophila HP1 gamma)  
  NM_009122  Satb1  912,677 526,688 258,601 3,529 Special AT-rich sequence binding protein 1  
  NM_010444  Nr4a1  110,153 83,316 31,593 3,487 Nuclear receptor subfamily 4, group A, member 1  
  NM_009741  Bcl2  106,187 52,904 31,479 3,373 B-cell leukemia/lymphoma 2  
  NM_019653  Wsb1  48,569 39,810 15,291 3,176 WD repeat and SOCS box-containing 1  
  BC095996  Tbrg3  56,298 30,368 17,729 3,176 Transforming growth factor beta regulated gene 3  
  NM_057172  Fubp1  215,456 138,576 68,947 3,125 Far upstream element (FUSE) binding protein 1  
  NM_010890  Nedd4  40,331 17,570 13,569 2,972 Neural precursor cell expressed, developmentally down-regulated 4  
  NM_001081251  Pbrm1  173,497 138,198 58,569 2,962 Polybromo 1  
  NM_207680  Bcl2l11  32,328 22,236 11,242 2,876 BCL2-like 11 (apoptosis facilitator), Bim 
  NM_019740 Foxo3  43,928 30,821 16,237 2,705 Forkhead box O3  
  NM_025359  Tspan13  129,215 94,391 49,125 2,630 Tetraspanin 13  
  NM_145541  Rap1a  162,029 119,903 62,101 2,609 RAS-related protein-1a  
  NM_010703  Lef1  347,967 201,569 134,638 2,584 Lymphoid enhancer binding factor 1  
  NM_007642  Cd28  107,729 77,978 45,134 2,387 CD28 antigen  
  NM_018851  Samhd1  129,085 93,684 54,569 2,366 SAM domain and HD domain, 1  
  NM_133352  Tm9sf3  83,251 65,569 36,242 2,297 Transmembrane 9 superfamily member 3  
  NM_145600  Zfp330  36,098 31,903 16,237 2,223 Zinc finger protein 330  
  NM_025356  Ube2d3  269,729 226,569 124,931 2,159 Ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast)  
  NM_008996  Rab1  49,069 39,777 23,070 2,127 RAB1, member RAS oncogene family  
  NM_008225  Hcls1  103,209 61,018 49,621 2,080 Hematopoietic cell specific Lyn substrate 1  
  NM_173364  Zfp445  46,351 45,028 23,164 2,001 Zinc finger protein 445  
  NM_001122893  Fyn  148,050 107,163 74,569 1,985 Fyn proto-oncogene  
  NM_010118  Egr2  24,327 12,254 12,254 1,985 Early growth response 2  
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Tbl. 7.2: List of previously described functions for each gene and considered aspects in the candidate selection.   
  Gene 
Symbol 
known functions and features  T cell related 
functions 
selection parameter 
  Dub2a  induced rapidly upon IL2 stimulation [169] ✓ highest SP1/3 ratio;  role in IL2 responsiveness 
  Ccr9  chemotaxis of precursors to thymus [170] ✓   
  Itm2a  induced during positive selection [171]  ✓ high SP1/3 ratio; upregulation upon positive selection 
  Lztfl1  negative regulator of BBSome transport to cilia [172]  high SP1/3 ratio; potential transcription factor;  SHH signaling 
  Cbx3  smooth muscle differentiation [173]    
  Satb1  Il2, Il2ra silencing, lymphoid lineage commitment [174, 175] ✓   
  Nr4a1  TCR signaling [176] ✓   
  Bcl2  apoptosis [177-179] ✓   
  Wsb1  turnover of IL21R [180] ✓   
  Tbrg3  -    
  Fubp1  c-myc expression, cell proliferation [181]    
  Nedd4  Cbl-b ubiquitination, TCR signaling [182] ✓ TCR threshold regulation; TCR sensitivity in selection 
  Pbrm1  histone acetylation [183]    
  Bcl2l11  apoptosis, negative selection [118] ✓   
  Foxo3  Treg development [184] ✓   
  Tspan13  potential tumorsupressor [185]    
  Rap1a  -    
  Lef1  T cell lineage commitment [186] ✓   
  CD28  costimulation [187] ✓   
  Samhd1  HIV-1 restriction factor in non-cycling cells [188, 189] ✓   
  Tm9sf3  -    
  Zfp330  -    
  Ube2d3  -    
  Rab1  member of Ras family     
  Hcls1  cytoskeleton remodeling, lymphocyte trafficking [190]    
  Zfp445  -    
  Fyn  TCR signaling [191] ✓   
  Egr2  thymocyte survival at DP stage [192, 193] ✓   
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Tbl. 7.3: Summary of results in GOF and LOF experiments for selected candidates. 
 
 
 
 
 
 
 
 
 Gene 
Symbol 
attempted GOF 
phenotype 
observed 
LOF phenotype 
observed 
  GOF LOF mRNA Protein  mRNA Protein 
  
Dub2a  y ongoing - - very low infection rates < 1%, levels of 
overexpression remain to be confirmed 
 -  -  
  
Itm2a  y ongoing - - 
increased frequency of Foxp3+ cells among Itm2a 
overexpressing CD4SP (approx. 7% 
CD4+Foxp3+), inconsistent 
 -  -  
  
Lztfl1  y y 7.9±3.4x 
approx. 
2x 
reduced frequency of Foxp3+ cells among Lztfl1 
overexpressing CD4SP (approx. 1,5 % 
CD4+Foxp3+) 
knockdown to 
25% 
- no differences  
  
Nedd4  y n - - 
increased double negative compartment in 
Nedd4 overexpressing cells, block at DN2/3 
stage, very low infection rates < 2% 
 -  -  
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Tbl. 8.1: List of 17 genes with increasing expression between the maturation stages. Ratio between SP1 and SP3 of ≤ 0.5 was set as a cut-
off and genes are listed according to the decreasing ratios.   
 
 
 
! Gene Accession 
Gene 
Symbol 
SP1 SP2 SP3 SP1/3 Ratio Gene Description 
!! NM_019391  Lsp1  61,903 89,302 125,936 0,492 Lymphocyte specific 1  
!! NM_013566  Itgb7  19,178 37,664 40,061 0,479 Integrin beta 7  
!! NM_146318  Olfr767  25,236 35,119 56,477 0,447 Olfactory receptor 767  
!! NM_010559  Il6ra  17,935 29,381 40,614 0,442 Interleukin 6 receptor, alpha  
!! NM_011346  Sell  42,881 98,875 100,830 0,425 L-selectin, lymphocyte  
!! NM_025800  Ppp1r2  7,058 11,272 17,356 0,407 Protein phosphatase 1, regulatory (inhibitor) subunit 2  
!! NM_009008  Rac2  63,470 96,431 184,236 0,345 RAS-related C3 botulinum substrate 2  
!! NM_029803  Ifi27l2a  13,244 26,903 38,680 0,342 Interferon, alpha-inducible protein 27 like 2A, ISG12 
!! NM_028595  Ms4a6c  13,563 40,903 40,650 0,334 Membrane-spanning 4domains subfamily A member 6C  
!! NM_008495  Lgals1  11,543 22,903 37,629 0,307 Lectin, galactose binding, soluble 1  
!! NM_011407  Slfn1  29,075 77,903 96,236 0,302 Schlafen 1  
!! NM_020561  Smpdl3a  3,682 6,697 12,254 0,300 Sphingomyelin phosphodiesterase, acid-like 3A  
!! NM_016740  S100a11  27,882 31,704 99,632 0,280 S100 calcium binding protein A11 (calgizzarin)  
!! NM_001135001  Ppp2r5c  58,597 211,507 211,507 0,277 Protein phosphatase 2 regulatory subunit B gamma  
!! NM_001033324  Zbtb16  11,390 18,237 43,981 0,259 Zinc finger and BTB domain containing 16  
!! NM_011055  Pde3b  11,235 24,933 51,903 0,216 Phosphodiesterase 3B, cGMP-inhibited  
!! NM_007901  S1pr1  6,716 33,678 64,371 0,104 Sphingosine-1-phosphate receptor 1  
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Tbl. 8.2: List of previously described functions for each gene and considered aspects in the candidate selection.   
 
 
 
!!
Gene Symbol known or speculated functions and features 
 
T cell related 
functions 
selection parameter 
!! Lsp1  calcium binding protein [194]   
!! Itgb7  intestinal homing [195] ✓  
!! Olfr767  -   
!! Il6ra  inflammation, Th17 polarization [196] ✓ polarization between tTreg and potentially ‘tTh17’ 
!! Sell  lymphocyte migration [197] ✓  
!! Ppp1r2  -   
!! Rac2  Rho family GTPase    
!! Ifi27l2a  IFNα-inducible adipocytokine [198]  unknown function 
!! Ms4a6c  -  predicted 'Foxp3-dependent gene'[135] 
!! Lgals1  T cell survival, TCR tuning [199] ✓  
!! Slfn1  cell proliferation and growth [200, 201] ✓ role in proliferation 
!! Smpdl3a  -  predicted 'Foxp3-amplified-gene' [135] 
!! S100a11  -   
!! Ppp2r5c  PP2A regulation, cell proliferation [202]   
!! Zbtb16  NKT differentiation [203] ✓  
!! Pde3b  cATP and cGTP metabolism, Treg development [135] ✓  
!! S1pr1  lymphocyte migration [204] ✓  
 
 
                                                                                                                                                                                         
46 
 
 
Tbl. 8.3: Summary of results in GOF and LOF experiments for selected candidates. 
 
 
 
 
 
 
 
 
  
Gene Symbol 
attempted GOF phenotype  
observed 
LOF phenotype  
observed 
  GOF LOF mRNA Protein mRNA Protein 
  Il6ra y n - - 
no surface       
expression of    IL6Rα by 
FACS staining, no 
differences 
 -  -  
  Ifi27l2a y n 7.4±6.3x - 
 
no differences 
 -  -  
  Ms4a6c y n - - no differences    
  Slfn1 y y 2.6x - no differences 
knockdown to 
40% 
 - no differences 
  Smpdl3a y n 9.2x - no differences - -  
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Fig. 4: Data verification and expression confirmation by real-time PCR for all differentially expressed genes according to microarray analysis. For 
all differentially expressed genes confirmatory real-time PCR reactions were designed and performed on sorted SP1,2 and 3. For the comparison, 
expression level of each transcript at SP1 stage was set as 1. Expressions at SP2 and SP3 were normalized to the level of SP1. Bar diagrams show means 
of duplicate reactions.
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Lentiviral construct design and experimental approach 
One possibility to study the function of a gene is through gain- and loss-of-function 
experiments. We decided to selectively upregulate or knockdown selected genes of 
interest.  
Therefore, we built a system in which we would infect bone marrow with a lentivirus 
and introduce elements needed for this interference. Further, we would monitor the 
development of the infected thymocytes and relate it to the uninfected or empty-
vector-infected controls.  
We built lentiviral vectors composed of following elements (Fig.6):  
Expression specificity regulating elements: We used elements derived from the 
CD4 gene composed of a minimal CD4 promoter and the proximal CD4 enhancer 
[205]. Further, we inserted an additional regulatory level by introducing a CD4 
silencer element, which allows transcriptional repression of CD4 expression in the 
CD8 cells and therefore limits the gene expression to DP and  CD4 SP T cells [206].  
2. Enhanced green fluorescent protein (eGFP), utilized as a reporter of infection 
and   construct expression. 
3.  T2a linker: This 54 bp sequence codes for a T2A peptide of Thosea asigna virus, 
a cis-acting-hydrolase element. The bicistronic construct composed of two open 
reading frames connected via T2A sequence is expressed in one transcript [207]. 
The ‘cleavage’ of the two proteins is mediated by ‘ribosomal skip’ mechanism, 
induced by terminal proline and penultimate glycine residues within the T2A peptide 
[208]. In this way, nearly stoichiometric amounts of both parts of construct are 
produced.  
4.  Gene of interest: This part carries the full coding sequence of each candidate 
gene. 
 
For the knockdown experiments we used the previously described system 
(Openbiosystems, Expression ArrestTM). Designed short-hairpin RNAs were cloned 
in the human miR30 backbone and expressed under the above-described regulatory 
elements (in detail in Material and methods). 
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Fig 5: Lentiviral vectors and expression in T cell lineages. A – Schematic representation of 
lentiviral vectors containing described elements for gene expression interference. B - Both vectors 
guarantee high expression in CD4 SP compartment. In the infections using the pan T cell vector all 
thymocyte subpopulations express the construct with the highest expression in CD4 SP and DP cells. 
In the case of CD4-specific vector the expression is mainly restricted to DP and CD4SP T cells.  C - 
Pictures of cells expressing eGFP and mCherry from a bicistronic construct confirm the principle 
behind the T2A peptide. 
 
The generated vectors provided us with strong tools to study the role of selected 
genes in the thymocyte development and further whole T cell life. We used these 
tools to perform bone marrow chimeras in polyclonal and TCR transgenic systems, 
in order to study general events and TCR / cognate-antigen interaction induced 
events related to these genes (Fig. 6). 
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Fig. 6: Generation of bone marrow chimeras. A – Donor mice were treated with 5’ fluorouracil (i.p.) 
to enrich hematopoietic stem cells (HSC). Upon four days, harvested bone marrow was cultured in 
cytokine cocktail containing IL3, IL6 and SCF until infection on the next day. Infected bone marrow 
cells were injected into lethally irradiated recipients. B – The scheme of bone marrow chimera 
combinations used for analysis in the polyclonal and TCR transgenic repertoire. 
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Candidate selection and confirmation of expression levels 
 
In the first set of bone marrow chimeras, we attempted the lentiviral gain-of-function 
for the selected candidates. Initially, we analyzed the efficiency of infection by 
percentage of GFP expressing cells.  
For three candidates Dub2a, Itm2a and Nedd4, we achieved infection efficiencies 
between 1-2% (Fig. 7). The infection rates remained low in infections with several 
different virus preparations and extended infection times. Therefore, we decided that 
the gain-of-function experiments for these candidates require further optimization. 
For IL6Rα, we obtained small populations of infected cells but were unable to show 
that IL6Rα is overexpressed on the surface of the cell. For the remaining candidates 
(Lztfl1, Slfn1, Ifi27l2a, Smpdl3a and Ms4a6c) we established a robust 
overexpression system and therefore narrowed down our focus on these molecules 
and their functions in T cell biology.  
 
 
 
Tbl. 9: List of candidates selected upon lentiviral gain-of-function experiments. One candidate 
(Lztfl1) was selected from the list of 28 genes with declining expression between the stages, and 
additional four candidates (Slfn1, Smpdl3a, Ms4a6c and Ifi27l2a) were selected from the list of genes 
with increasing expression.  
 
 
 
 
 
 
 
List of final candidates  
Gene symbol Gene description 
Lztfl1 leucin zipper transcription-factor-like 1 
Slfn1 schlafen 1 
Smpdl3a sphingomyelin-phosphodiesterase acid-like-3a 
Ms4a6c membrane-spanning 4-domains, subfamily A, member 6C 
Ifi27l2a interferon, alpha-inducible protein 27 like 2A 
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Fig. 7: Initial screen by gain-of-function experiments. The depicted plots present CD4 and CD8 
staining of thymi in bone marrow chimeras and infection rates of CD4 cells for each candidate. Each 
plot represents 20 000 events. Numbers above gates present mean frequency ± s.d. of populations 
within gates. For empty vector controls n=7, for Nedd4 n=2, for Dub2a n=4, for Itm2a n=8, for IL6Rα 
n=3, for Smpdl3a n=4, for Slfn1 n=8, for Ms4a6c and Lztfl1 n=9 and for Ifi27l2a n=7.  
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Current knowledge on selected candidates 
Lztfl1 (leucine-zipper transcription factor-like 1) was one of the candidates with the 
strongest downregulation between the ‘youngest’ and the ‘oldest’ CD4SP 
thymocytes, and as a potential transcription factor, we considered this gene to be a 
promising candidate.  
To date, little is known about the functions of Lztfl1. The first description of the Lztfl1 
originates from a sequencing of 250 kbp map of short arm on human chromosome 3, 
3p21.3 (C3CER1), a segment commonly lost in various tumors [209].   
Lztfl1 orthologues were found in all vertebrates but not in invertebrates, plants or 
fungi. The mouse orthologue of Lztfl1 was mapped to the chromosome 9. The 
overall similarity between human and mouse cDNA is 86.6 % [172].  
Lztfl1 was named due to the presence of the leucine zipper pattern, a helical strech 
of amino acids in which leucine occurs every seven amino acid residues. This zipper 
domain is part of the coiled coil at the C terminus while the rest of Lztfl1 seems to 
have an alpha helical structure according to the bioinformatic predictions [209].  
Further, one study has related loss of Lztfl1 to occurrence of gastric cancer in human 
samples and found that Lztfl1 stabilizes E-cadherin-mediated adhesive junctions and 
therefore inhibits metastasis of cancer cells via epithelial-mesenchymal transition 
[210].  
Lately, two studies related Lztfl1 to the ciliary transport machinery [172, 211]. The 
central part of this process is played by a molecular complex, called BBSome, 
involved in transport of signaling molecules and receptors to the ciliary membrane. 
This complex has been named after the Bardet-Biedl-Syndrome (BBS), a human 
genetic disorder related to ciliary disfunction – mainly diagnosed by postaxial 
polydactily, retinitis pigmentosa, obesity, cognitive impairment and kidney alteration 
[212, 213]. 
Seo et al., were able to show that Lztfl1 interacts with Bbs9 and plays a particular 
role in the BBSome-related transport of SHH (sonic hedgehog) proteins to the cilia 
[172]. Further, Marion et al., described a first patient with 5bp deletion in Lztfl1 locus 
leading to a premature stop codon and BBS-like disease with increased levels of 
sonic hedgehog related proteins – Smo, Ptch1, Gli1, Gli2 and Gli3 [211].  
Taken together, Lztfl1 was supposed to negatively regulate the transport of SHH 
proteins via BBSome in the cilia, while its roles in the immune system are 
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unexplored. Therefore, we decided to study this protein and its functions in the T cell 
system primarily.  
 
Slfn1 is a member of the Schlafen family. The upregulation of Schlafen family 
molecules in thymocytes upon positive selection emerged from a subtractive 
hybridization of two thymocyte cDNA libraries between non-positively selected 
AND.4R (AND TCR on H-2h4 haplotype) and successfully selected AND.B6 
thymocytes (AND TCR on H-2b haplotype) [214].  Via this approach, Slfn1,2, 3/6 and 
4/7 were found to be developmentally regulated in the thymocyte maturation. Slfn1 
and 2 were shown to be downregulated upon TCR activation, whereas 3/6 and 4/7 
were upregulated. The Slfn1 deficient mouse had normal CD4 and CD8 ratios in the 
thymus and lymph nodes. Later on, Slfn1 molecule was shown to downregulate 
cyclin D1 and lead to cell cycle arrest. We were interested in exploring how Slfn1 can 
impact thymic selection and maturation progression in connection to survival at the 
CD4 SP stage. 
 
Ms4a6c is a member of a novel membrane protein family, MS4A, identified in the 
hematopoietic cells and structurally related to the cell surface molecules like CD20 
and high-affinity IgE receptor β-chain, FcεRIβ. There are at least 12 subgroups 
(Ms4a1-12) of Ms4a proteins and each member is characterized by the presence of 
four transmembrane domains [215, 216]. The function of Ms4a6c is unknown and 
according to the gene expression data bank Immgen, it has the highest expression in 
naive CD4 T cells. 
 
Smpdl3a, sphingomyelin-phosphodiesterase-acid-like 3a, was first described in a 
whole-genome screen for the direct liver X receptor (LXR) target genes, as LXR 
binds to Smpdl3a promoter upon stimulation. Further, a yeast 2-hybrid system 
described Smpdl3a to be a direct binding partner of a tumor suppressor gene 
DBCCR1 (deleted in bladder cancer chromosome region 1) in human bladder tumors 
[217, 218]. To date, there are no described roles of Smpdl3a in the immune system. 
Its predicted expression is highest in the memory CD4 T cells and Tregs. 
 
Ifi27l2a or ISG12 has been discovered by an oligo-capping signal sequence trap, a 
technique for screening the cDNA of secretory proteins. This technique was used for 
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screening in adipocytes upon interferon α exposure and identified Ifi27l2a as a 
potential IFN α – inducible adipocytokine [198]. According to the Immgen database, 
Ifi27l2a has the highest expression at the stage of CD4 SP T cells. 
 
Overexpression of selected candidates and the effects on the thymic Treg 
compartments 
 
The basis of our study is the differential propensity of maturing thymocytes to enter 
the regulatory T cell lineage and therefore we primarily investigated the formation of 
Treg compartments upon the overexpression of each candidate gene (Fig. 8). For 
the four candidates Slfn1, Smpdl3a, Ifi27l2a, Ms4a6c, we did not observe any 
differences in Treg generation between uninfected and infected compartments. In 
the infection with the empty vector controls, the GFP- CD4 SP subpopulation 
contained 3.2 ± 1.1 %Tregs versus 2.8 ± 0.9 % (p=0.434) in the GFP+ CD4 SP cells. 
For the overexpression of Ifi27l2a 2.8 ± 1.2 % versus 2.4 ± 1.2 % (p=0.565) Tregs 
were observed between GFP- and GFP+ populations. In the case of Slfn1, the 
overexpression did not influence the Treg compartment leading to the similar Treg 
frequencies with 2.2 ± 0.9 % in the GFP- and 2.7 ± 1.5 % (p=0.383) Tregs in the 
GFP+ cells. Similarly, Ms4a6c gain-of-function did not impact Treg pools with 2.7 ± 
0.6 % versus 2.9 ± 1.5 % (p=0.754) Tregs. The overexpression of Smpdl3a induced 
only slight reduction in thymic Treg compartment with 4.1 ± 1.1 % Tregs in the GFP- 
cells versus 2.8 ± 0.9 % (p=0.107) in the GFP+ cells. 
Finally, the overexpression of one candidate, Lztfl1, resulted in a significantly 
reduced thymic Treg compartment with 3.3 ± 0.8 % Tregs in GFP- and 1.8 ± 0.5 % 
(p=0.00001) Tregs in the GFP+ CD4 SP cells (Fig. 8). 
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Fig. 8: Effects of gene overexpression on the thymic regulatory T cell compartment. The 
depicted plots present thymic Treg compartments within uninfected and infected CD4SP populations 
for each candidate. Numbers above and within gates present mean frequency ± s.d.. Bar diagrams 
present frequency of Foxp3+ cells in each CD4SP GFP- and CD4SP GFP+ compartment. For empty 
vector controls n=7, for Smpdl3a n=4, for Slfn1 n=8, for Ms4a6c and Lztfl1 n=9 and for Ifi27l2a n=7. 
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One potential explanation for the absence of an evident phenotype would be a low 
level of overexpression. In order to exclude this we performed RT PCR analysis for 
the majority of candidates (Fig. 9a) and showed certain level of overexpression. The 
levels of overexpression varied between two and sixteen times relatively to the 
expression levels of respective candidate in the uninfected subpopulation of CD4SP 
thymocytes. For Lztfl1 we showed the overexpression also at the protein level by 
Western blotting (Fig. 9b). 
 
 
         A     B 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9. Overexpression of selected candidates upon lentiviral infection in bone marrow 
chimeras. A – Bar diagram represents the overexpression of candidate mRNA in infected CD4SP 
thymocytes (GFP+), normalized and compared to the uninfected CD4 SP thymocytes (GFP-). The 
represented bars depict mean ± s.d. of three experiments for Lztfl1 and Ifi27l2a, while for Smpdl3a 
and Slfn1 means of two experiments are depicted. B – Western blot showing overexpression of Lztfl1 
in the total CD4 SP thymocytes of a chimeric and wild type thymus.  
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Lztfl1 overexpression leads to reduced thymic regulatory T cell compartment 
 
In the initial screen by the lentiviral gain-of-function, we showed that one of the 
selected candidates, Lztfl1 influences the formation of the thymic Treg compartment. 
The thymic Treg pool in the Lztfl1-overexpressing population was decreased up to 
50% and made only 1.82 ± 0.5 % instead of 3-4 % of all other CD4+SP thymocytes 
(uninfected and empty-vector-infected) (Fig. 10).  
 
   A             B 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Effects of the Lztfl1 overexpression on the thymic Treg compartment. A – The plots 
depict CD4 and CD8 staining of thymi in bone marrow chimeras and gating on the uninfected and 
infected CD4 SP thymocytes to assess the frequency of thymic regulatory T cells in each 
compartment. B – The plots depict thymic Treg pools in the Lztfl1-overexpressing and the control 
chimeras. Numbers in the gates represent frequencies ± s.d. of n = 13 for control and n = 12 for 
overexpression chimeras. 
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Effects of Lztfl1-overexpression on the peripheral Treg pool 
 
In the analysis of the peripheral Treg pool, the previous observation made in the 
thymus of the bone marrow chimeras remained evident but the difference had a 
lower extent and a higher variability, with 11.91 ± 1.2 % in the uninfected control 
versus 6.16 ± 0.8 % (p=0.002) in the Lztfl1-overexpressing population (Fig. 11). 
Taken together, the overexpression of Lztfl1 in CD4 T cells leads to reduced thymic 
and splenic regulatory T cell pools. 
 
      A       B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11: Effects of the Lztfl1 overexpression on the splenic Treg compartment. A – The plots 
depict CD4 and CD8 staining of splenocytes in bone marrow chimeras and gating on the uninfected 
and infected CD4+ T cells to assess the frequency of peripheral regulatory T cells in each 
compartment. B – represents splenic Tregs in the overexpressing and control chimeras, each n = 7. 
Diagrams below display frequencies in each sample.  
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Focusing on the potential roles of Lztfl1 in the thymic Treg development, we decided 
to perform the bone marrow chimeras in a very well established Treg development 
system utilizing TCR-HA and Aire-HA models.  
We overexpressed Lztfl1 in TCR-HA thymocytes and examined the cognate-antigen 
induced Treg development. We hypothesised that the effects of Lztfl1 
overexpression decrease the Treg compartment in TCR-HA x Aire-HA system, 
confirming and emphasizing the observation from the experiments in the polyclonal 
repertoire. However, we could not evidence any significant change in the Treg 
development, although a certain tendency toward the reduction of the Treg 
compartment by the overexpression of Lztfl1 in the presence of cognate antigen was 
measurable, with 18.5 ± 6.6 % in GFP- TCR-HA population versus 13.2 ± 8.1 % 
(p=0.133) in the GFP+ population (Fig. 12). 
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Fig. 12: Analysis of TCR-HA+ CD4 T cells in Aire-HA recepients upon bone marrow infection with Lztfl1- or control-virus. The plots depict staining for 
Treg cells upon gating on TCR-HA+ CD4+ T cells in the thymi of Balb/c or Aire-HA recepients and the numbers within gates represent mean of frequencies ± 
s.d. Diagrams represent frequencies ± s.d. of n = 8 in each group.  
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Knockdown of Lztfl1 in CD4 SP thymocytes has no impact on Treg pools 
 
In the attempt to further validate the results of lentiviral gain-of-function experiments, 
we performed knockdown for Lztfl1. Therefore we generated three different designer 
miRNAs, assembled of miR30 backbone and predicted, Lztfl1-targeting shRNAs 
(microRNA-adapted shRNA expression vectors). We tested the efficiency of three 
different miR constructs by RT PCR for Lztfl1, normalizing the results to the empty 
vector (miR30) infections. From the obtained results of two independent experiments 
we decided to focus on Lztfl1 miR1, which reduced the expression of Lztfl1 to around 
20% of the level in the control (Fig. 13).  
 
                  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13: Expression of Lztfl1 in CD4SP thymocytes in bone marrow chimeras using three 
different designer miRNA knockdown constructs. The bar diagrams depict RT PCR 
measurements of Lztfl1 expression in CD4 SP with constructs carrying different shRNAs agains Lztfl1 
or miR30 (empty vector control) in two different experiments. The expression level in the infection with 
miR30 control was set as one and all the other infections were normalized to it. 
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We infected bone marrow with either constructs containing Lztfl1 miR1 or only 
miR30 (empty vector) and analyzed thymic development in the knockdown of Lztfl1. 
The frequencies of CD25+Foxp3+ CD4 thymocytes were very similar between all 
uninfected and infected groups. This result shows that the reduction in Lztfl1 levels 
does not impact the formation of Treg compartment, with 2.4 ± 0.4 % Tregs in the 
uninfected compared to similar frequency of 2.7 ± 0.3 % (p=0.631) Lztfl1miR1 
infected CD4SP. Nevertheless, it remains unclear whether the residual amounts of 
Lztfl1 may be sufficient to maintain the normal functions of Lztfl1.  
 
A                          B
 
 
Fig. 14: The effects of Lztfl1 knockdown on the thymic Treg pool. Presented plots depict thymic 
Treg compartments in bone marrow chimeras in infections with Lztfl1 miR1 virus and miR30 virus 
(empty control) upon gating on CD4 SP and then on uninfected and infected populations. Numbers in 
the gates present mean frequencies ± s.d..The diagram presents Treg frequency in each set of 
chimera for n = 4. 
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From these observations and experiments, we concluded that the most efficient and 
conclusive way to study the roles of Lztfl1 would be to generate a mouse model, 
carrying Lztfl1 alleles with conditional knockout potential (floxed) and to breed it to 
diverse CRE models. Therefore, we generated ES cell clones containing a targeting 
construct for conditional knockout of Lztfl1 (Fig. 15). 
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Fig. 15: Scheme of the Lztfl1 targeting construct. This scheme represents the targeting construct created by KOMP targeting facility 
(www.komp.org, Knockout Mouse Project). The major features of the construct are the floxed exon four, surrounding loxP sites, LacZ reporter and 
neomycin resistance elements flanked by FRT sites. Through the utilization of FRT deleter one can remove the reporter and resistance elements and 
end with the conditional allele of Lztfl1. Further any CRE deleter can be used to conditionally and specifically remove Lztfl1.  
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Further selection and focus on the remaining candidates 
 
Upon the initial screen via the described lentiviral overexpression system, we 
extended our analyses and included the availability of the knockout mouse models in 
the candidate selection. For one of the previously selected candidates, Nedd4, a 
conditional knockout mouse model was available and we approached the study of 
Nedd4 in the thymocyte development. 
 
Current knowledge about Nedd4 
 
The discovery of Nedd4 (neural precursor cell expressed, developmentally 
downregulated protein 4) is based on the subtraction cloning of developmentally 
downregulated genes between embryonic and adult mouse brain [219, 220]. Later, 
Nedd4s role in the regulation of axonal sensitivity in Drosophila and neural crest 
closure in higher organisms have emerged from its interactions with developmentally 
important molecules like Commissureless, roundabout and Rap2A [158, 221]. The 
complete deficiency on Nedd4 is due to this lethality at the embryonic day 12. 
Nedd4 is one of several E3 ubiquitin ligases described in the immunological context. 
It is a HECT (homologous to the E6-AP carboxyl terminus) family E3 ubiquitin ligase, 
meaning that it is uniquely responsible for the substrate specificity and performs 
ubiquitin transfer onto a targeted protein in association with an E2 ligase. The protein 
structure of Nedd4 is characterized by the presence of C2 domain, three WW 
domains and HECT domain. The C2 domain brings the Nedd4 molecule into the 
proximity of diverse adaptor proteins, while WW domains typically determine 
substrate specificity. The HECT domain carries intrinsic catalytic activity. 
Interestingly, Nedd4 has been described to mainly perform K63 ubiquitination 
instead of classical K48, which indicates proteosomal degradation. K63-linked 
ubiquitination can have different meanings than degradation, like transport or 
activation [222, 223]. 
The major work that relates Nedd4 to T cells has been performed on peripheral T 
cells in the context of activation [182, 224]. At the same time, no data on roles in 
thymocyte biology has been gathered. From the experiments on Nedd4 deficient 
fetal liver chimeras, we know that Nedd4 deficient T cells proliferate poorly and have 
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increased levels of Cbl-b due to the lack of Nedd4-mediated targeting for 
degradation [182]. Nedd4 deficient T cells in this system maintain their naïve 
phenotype and produce less IL2 upon activation, leading to the conclusion that this 
deficiency leads to hyporesponsiveness. Further, B cells undergo class switching 
with lower frequency, which might result from moderate T cell activation and 
unsuccessful help to the B cells, or it might be B cell intrinsic. According to this 
model, there are no impacts on the thymic T cell development and selection 
processes or further Treg generation [182]. As this model describes a phenotype 
based on the regulation of TCR responsiveness, we reasoned that the thymocyte 
development might need reconsideration in a more clear approach, using conditional 
ablation of Nedd4.  
The data provided from the work of Yang et al. based the rationale to ask how these 
potentially hyporesponsive thymocytes perform in the selection processes. 
Moreover, the relatively slight effects of Nedd4 on the peripheral TCR signal fine-
tuning proposed a very interesting tool, in the context of TCR signal strength studies 
of the negative selection versus regulatory T cell development.  
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Expression profile of Nedd4 among T cell subsets 
 
We firstly confirmed the expression pattern by real-time PCR over a range of 
relevant T cell populations (Fig. 16). Consistent with the microarray results, the 
expression level of Nedd4 decreases from the CD4 SP1 stage (rel. expression 1,00) 
over the SP2 stage (rel. expression 0.599) to SP3 stage (rel. expression 0.196). The 
lowest expression level of Nedd4 was found to be at the stage of a naive T cell from 
peripheral lymphatic organs, spleen and pooled lymph nodes. These observations 
indicate that the level of Nedd4 decreases with the developmental stage from 
selected thymocytes to the fully developed T cells in the periphery.  
When we analyzed the expression of Nedd4 at the stages prior to T cell selection 
process, we observed an interesting expression pattern in the double negative 
compartment. Prior to the T cell lineage commitment, at the stages of early thymic 
progenitor and double negative stage 1, we detected relatively low Nedd4 
expression compared to the expression at the following stages, double negative 2,3 
and 4. According to these results, we assumed that Nedd4 might play an important 
role at the double negative stage 2-3.  
As the stimuli through the TCR play one of the most important roles in the education 
and the lifetime of a T cell, we compared the expression of Nedd4 between the pre- 
and post-positive selection double positives. In this comparison the level of Nedd4 
decreases with the ongoing positive selection.  
In addition, in the periphery we observed ten-fold increase in mRNA expression 
levels of Nedd4 between the naive (rel. expression 0.003) and memory T cell (rel. 
expression 0.037).  
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Fig. 16: Relative expression of Nedd4. Bar diagram represents means of two real-time PCR 
reactions for each T cell population. Expression of Nedd4 at the SP1 stage was set to one and all 
further expressions were normalized to that level.  
 
 
We compared our expression data to the expression profiles of Nedd4 in the gene 
expression data base, Immgen (http://www.immgen.org/) and could confirm the 
expression levels for the majority of populations. In the case of DN1 subset we 
observed lower levels as those reported by Immgen. This discrepancy might result 
from different gating strategies, as we did not differentiate the between early thymic 
precursors (ETP) and ETP to DN2a transitional stages, in order to maximize our 
sorting yield and efficiency. Nevertheless, the expression profile generated allows us 
an overview of Nedd4 expression in the thymus. 
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Conditional deletion as experimental approach to study Nedd4 in T cell biology 
 
The study of Nedd4 expression pattern over the T cell lineage subsets and its 
dynamics founded a basis to analyse the effects of Nedd4 deficiency in the immune 
system and T cells, in particular.  
The major advantage in this experimental intention was the availability of a 
conditionally deficient Nedd4 mouse model [158].  
This model was designed to carry an exon flanked by the loxP sites between the C2 
and the first WW domain of Nedd4. Via crossing to any possible CRE deleter model, 
this would allow the ablation of Nedd4 expression at the particular level.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17: Construct of Nedd4 conditionally deficient allele. The targeting region is between C2 and 
the first WW domain of Nedd4. Upon crossing with a FRT deleter, elements like LacZ reporter and 
neomycin resistance have been removed and the construct was left with a loxP flanked exon ready 
for conditional ablation.   
 
In order to investigate the roles of Nedd4 in the T cell development, we decided to 
utilize four different CRE deleters: Vav-, Lck-, CD4- and Foxp3-CRE. Undertaking 
this approach, we wanted to dissect the study of Nedd4 at the different 
developmental stages and relate potential phenotypes to the stage-specific functions 
of Nedd4.  
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Fig. 18: Four different CRE deleters for stagewise Nedd4 deletion. A – In order to address stage-
specific roles of Nedd4, we utilized four different CRE deleters, starting with the earliest Vav-CRE 
(deletion at the stage of hematopoietic stem cells, HSC). Over the Lck-CRE (deletion at the DN2/3 
stage), to the CD4-CRE (deletes at the DP stage). The Foxp3-CRE delete starts at the stage of 
CD4+Foxp3+ thymocytes. B- We assessed the efficiency of CD4-CRE deletion by Western blotting 
using the total thymi of CD4-CRE Nedd4+/+ and CD4-CRE Nedd4fl/fl mice. We performed 1:3 dilutions 
of the cell lysates in order to reliably quantify Nedd4 amounts at the protein level. The deletion 
efficiency of Nedd4 was considered to be adequate, as the estimation of Western blot shows 
reduction in Nedd4 protein below 60%. 
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Thymocyte subsets and phenotypical characteristics upon Nedd4 ablation 
 
In the primary experiments, we analyzed the thymi of the four described Nedd4 
deletion models (Vav-, Lck-, CD4-, or Foxp3-CRE x Nedd4fl/fl) and compared it to the 
respective controls carrying the wild type loci of Nedd4 (Vav-, Lck-, CD4-, or Foxp3-
CRE x Nedd4+/+). The overall thymic morphology and cellularity was very similar 
between the examined genotypes of each model.  
 
We firstly investigated the CD4 SP developmental stages using the CD4-CRE 
deleter (Fig. 19 and 20). Determined by CD4 and CD8 staining, double positive 
compartments of both genotypes did not vary significantly; 86.4 ± 2.5 % in the WT 
versus 83.6 ± 3.9 % (p=0.157) in the conditional knockout (cKO), followed by 
changes of similar extent in CD4 SP: 6.6 ± 1.4 % in WT and 7.8 ± 2.4 % (p=0.208) in 
the cKO and CD8 SP: 1.6 ± 0.2 % in the WT and 2.0 ± 0.2 % (p=0.124) in the cKO 
(Fig 19A).  
 
Further, the ablation of Nedd4 did not show any effect on the distribution of the three 
CD4 SP subpopulations: SP1 (6C10+CD69+) with 32.2 ± 1.4 % in WT and 34.7 ± 0.4 
% (p=0.123) in the cKO, SP2 (6C10-CD69+) with 19.1 ± 0.6 % in WT and 17.1 ± 1.1 
% (p=0.166) in the cKO, SP3 (6C10-CD69-) with 30.9 ± 1.6 % in WT and 29.2 ± 1.0 
% (p=0.405) in the cKO (Fig. 19B). 
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Fig. 19: Analysis of the thymi and CD4 SP compartments of the Nedd4 deficient mice. Depicted 
plots represent thymi of CD4 CRE mice (CD4-CRE Nedd4+/+) and mice carrying CD4-CRE-mediated 
Nedd4 deletion (CD4-CRE Nedd4fl/fl). A - General distribution of thymocytes in both genotype 
combinations (n=6). B - Distribution CD4 SP subsets, SP1,2 and 3 in both genotypes. Diagrams on 
the right show frequency means ± s. d. of subpopulations for both genotypes CD4-CRE Nedd4+/+ 
(black bars) and CD4-CRE Nedd4fl/fl (red bars).  
 
Next, we analyzed the expression of CD3 molecule between the DP and CD4 SP 
stages in both genotypes. As our hypothesis would assign Nedd4 to be a TCR 
positive regulator, we speculated that the effects of positive selection in the absence 
of Nedd4 would affect CD3 upregulation at the single positive stages. However, both 
Nedd4 deficient and sufficient DP thymocytes were able to enhance CD3 expression 
upon positive selection with equal quality (Fig. 20A).  
Further, we wanted to investigate the proliferative capacity of thymocytes in both 
genotypes. We used Vav-CRE model in order to include DN compartments in the 
analysis. We measured the Ki67 expression in diverse thymocytes populations. 
Nevertheless, in this aspect both groups compared showed indistinguishable results 
throughout all subpopulations (Fig. 20B).  
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Fig. 20: Expression of CD3 ζ chain and proliferation marker, Ki67. A - Histogram overlays of CD3 
ζ chain between the CD4-CRE x Nedd4+/+ (black lines) and CD4-CRE x Nedd4fl/fl (red lines) DP and 
CD4 SP cells. B – Expression of the proliferation market Ki67 on the DN, DP, CD4SP and thymic 
Tregs between the Vav-CRE x Nedd4+/+ (black lines) and Vav-CRE x Nedd4fl/fl (red lines) 
 
 
Due to the Nedd4 expression profile, we were interested to see potential changes in 
the double negative thymocyte compartment. We utilised Vav-CRE deleter for this 
analysis, to allow sufficiently early Nedd4 ablation. 
The double negative (lineage negative) compartment of Nedd4 sufficient and 
deficient thymi seemed to segregate normally into all double negative stages 1 to 4 
(Fig. 21A).  Double negative population 1 contributed with 9.7 ± 1.5 % in WT and 8.2 
± 1.4 % (p=0.498) in cKO, followed by the small population of double negatives 2 
with 2.6 ± 0.4 % in WT and 2.1 ± 0.5 % (p=0.427) in cKO. The two larger populations 
of double negative 3 and double negative 4 were similarly contributing with 45.6 ± 
5.9 % in WT and 57.6 ± 3.9 % (p=0.120) in cKO for the former and with 33.1 ± 5.4 % 
in WT and 31.9 ± 3.6 % (p=0.859) in cKO for the latter population.  Additionally, the 
frequences of early thymic progenitor were also very similar with 4.3 ± 0.2 % in WT 
and 4.1 ± 1.1 % (p=0.844) in cKO (Fig. 21B).  
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Fig. 21: Early thymocyte developmental stages in the absence of Nedd4. A - Depicts double 
negative compartments of Vav-CRE Nedd4+/+and Vav-CRE Nedd4fl/fl thymi and the diagram 
represents frequency means ± s.d. of each double negative population 1-4. B – Staining for ETP 
(early thymic precursor) and the frequency for each genotype are represented upon gating on lineage 
negative cells and CD44 and c-Kit positive cells.  
 
The events at the double negative stage involve mainly commitment to the T cell 
lineage and the β selection, leading to the formation of preselection pool of αβ T 
cells. The major role in this process is played by preTCR signaling that is essential 
for the lineage commitment between the αβ versus γδ T cells. Therefore, we 
investigated the presence of γδ T cells in the Nedd4 deficient thymi.  The frequency 
of γδ T cells in the cKO was 0.09 ± 0.02 % and therefore very similar to that of WT, 
0.12 ± 0.01 % (p=0.285)  (Fig. 22A). Furthermore, we investigated the generation of 
NKT cells in Vav- and CD4-CRE constellations. As for the γδ T cells, the ablation of 
Nedd4 did not have any effect on the NKT cell pool in both genotypes, with 0.2 ± 
0.05 % in WT and 0.27 ± 0.06 % (p=0.479) in cKO (Fig. 22B). 
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Fig. 22: γδ and NKT cell development in Nedd4 sufficient and deficient thymocytes. A – The 
plots depict percentages of γδ T cells upon ablation of Nedd4. Numbers in gates represent means of 
frequencies of gated population upon staining for CD3 and TCRγ on total thymocytes. B – NKT cells 
upon staining for the major markers TCRβ and CD1d tetramer PBS-57 (Tet) and gating on whole 
thymocytes. On the right frequency means ± s.d. are represented. For γδ T cells n=6 and NKT cells 
n=3.  
 
Taken together, we were unable to identify any changes or defects in T cell 
development by the absence of Nedd4 at the thymocyte stage and moved on toward 
the search for potential differences in the peripheral immune organs.  
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Nedd4’s potential roles in the peripheral T cell immunity 
 
For the investigation of the events ongoing in the periphery, we screened three major 
sites: spleen, pooled peripheral lymph nodes and mesenteric lymph nodes. At the 
first glance, mice conditionally deficient in Nedd4 by CD4-CRE showed normal CD4 / 
CD8 ratios and frequencies in the periphery. CD4 T cell frequencies were 13.3 ± 0.9 
% in the CD4-CRE Nedd4+/+ and 10.4 ± 2.3 in the CD4-CRE Nedd4fl/fl (p=0.316) (Fig. 
23A). Utilising other CRE models like Vav- and Lck-CRE we observed similar results 
and also no changes in CD8 frequencies.  
The activation status of the CD4 T cells, measured by the expression of CD62L and 
CD44 was very similar between both genotypes; frequency of naïve CD4 T cells was 
74.6 ± 2.4 % in WT and 75.8 ± 2.2 % (p=0.705) in cKO. The memory pools were 
also very similar with 14.4 ± 1.3 % in WT and 13.0 ± 1.6 % (p=0.531) in cKO (Fig. 
23B).   
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Fig. 23: CD4 and CD8 staining of splenocytes. A - CD4 and CD8 T cells in the spleens of CD4-
CRE x Nedd4+/+ and CD4-CRE x Nedd4fl/fl mice. The numbers within gates represent frequencies of of 
each cell population. B – CD62L and CD44 staining for the activation status of CD4 T cells; CD4-CRE 
Nedd4+/+ (black bars) CD4-CRE Nedd4fl/fl (red bars).  
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The expression of Nedd4 in the peripheral Tregs was shown to be higher than the 
expression in the naive cells (Fig. 16). We examined thymic and peripheral Treg 
pools for the frequency of the CD25+Foxp3+ T cells and expression of their common 
markers (Fig. 24).  
The frequencies in the thymus, spleen, peripheral and mesenteric lymph nodes were 
very similar between the CD4-CRE Nedd4+/+ and CD4-CRE Nedd4fl/fl. Very same 
result was obtained in the experiments using Foxp3-CRE deleter. In the thymi of 
CD4-CRE Nedd4+/+ mice 2.7 ± 0.1 % Foxp3+ T cells were found, which resembles 
the frequency of Foxp3+ cells in the CD4-CRE Nedd4fl/fl situation, 2.8 ± 0.3 % (p=0. 
823) (Fig. 24A). The levels of the Treg marker expression like CTLA4, GITR, CD28 
and CD122 (IL2R-β chain) remained unaffected both in the thymus and the 
peripheral organs with the absence of Nedd4 (Fig. 24B). In the pools of the 
peripheral lymph nodes for both genotypes, we found similar frequencies of Tregs 
with 13.2 ± 0.6 % and 13.6 ± 0.7 % (p=0.700). Consistent with this observation, 
frequencies in the spleen did not differ between both genotypes with 7.9 ± 0.2 % in 
WT and 7.6 ± 0.3 % (p=0.349) in the cKO. 
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Fig. 24: Regulatory T cell compartments. A – The frequency of thymic Treg ccells in both 
genotypes CD4-CRE Nedd4+/+ and CD4-CRE Nedd4fl/fl is presented. B - The histogram overlays show 
the expression of common Treg markers between two genotypes (black lines represent CD4-CRE 
Nedd4+/+ and red lines represent CD4-CRE Nedd4fl/fl). C – The staining of regulatory T cells in the 
pooled lymph nodes and in the spleen for each genotype.  
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TCR repertoire in Nedd4 sufficient and deficient T cells  
 
During the process of negative selection the TCR signal strength has an essential 
role in T cell life and lineage determination. We considered that Nedd4 deficiency 
and disruption of TCR signal fine-tuning might influence the V α and V β chain 
repertoire. Therefore, we investigated the frequency distribution of diverse V α and V 
β chains in the CD4 T cells between the two genotypes in the thymus and the 
spleen. Nevertheless, were did not identify any particular specificities that were 
affected by the lack of Nedd4 (Fig. 25).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 25: Distribution of T cell receptor V α and β chains in the thymus and spleen. In black bars, 
CD4SP thymocytes of CD4-CRE Nedd4+/+ and in grey those of CD4-CRE Nedd4fl/fl are depicted. For 
the frequencies in the spleen, red bars represent CD4-CRE Nedd4+/+ and light red CD4-CRE Nedd4fl/fl 
(n=2). 
 
 
In summary, Nedd4 deficient and sufficient thymic and mature T cells, as well as 
Tregs, did not differ in the frequency or any examined phenotypic parameters. Next, 
we extended our analysis to the functional properties and challenged the cells in 
several functional assays to compare their responses to diverse stimuli.  
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Proliferation and IL2 production in the absence of Nedd4 
 
Firstly, we examined the proliferative capacity of Nedd4 sufficient and deficient 
CD4SP thymocytes upon TCR stimulation. Thymocytes from both mice proliferated 
poorly upon αCD3 and αCD28 stimulation, as expected. Interestingly, Nedd4 
deficient thymocytes diluted CFSE less than wild type thymocytes indicating even 
lower degree of proliferation in the absence of Nedd4 (light blue and red, filled 
histograms) (Fig. 26).  
By the addition of 10U IL2, the proliferative capacity of Nedd4 deficient cells was 
increased to the initial level of Nedd4 sufficient cells (light blue line and red filled 
histogram). The addition of 100U IL2 could not overcome the defects of Nedd4 
deficient cells and further increase the degree of proliferation (light and dark blue 
lines). In the case of Nedd4 sufficient cells (brown and red lines) the addition of 
extrinsic IL2 enhanced the proliferation, as well. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 26: CFSE dilution of αCD3/αCD28 stimulated CD4 SP thymocytes. The proliferation of CD4 
SP thymocytes of each genotype was assessed in the absence and presence of IL2. Without the 
addition of IL2 Nedd4 deficient thymocytes proliferated less but this impairment was reconstituted 
upon addition of 10U IL2. Additional IL2 could not increase the level of proliferation in Nedd4 deficient 
thymocytes to the level of Nedd4 sufficient once.  
 
In order to confirm this result we compared two populations in an IL-2 ELISA for a 
range of αCD3 antibody concentrations. We could confirm that Nedd4 deficient 
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thymocytes produce less IL2 and this finding is prominent at the αCD3 levels that 
are sufficient for the full TCR activation (Fig. 27). 
 
 
 
 
Fig. 27: IL2 production of Nedd4 sufficient and deficient CD4 SP thymocytes. The production of 
IL2 assessed by ELISA at different concentration of αCD3 antibody. At the high concetrations of 900 
and 300 ng/ml Nedd4 deficient cells produced less IL2, while at the lower concentrations cells most 
likely did not experience full activation.  
 
We reasoned that Nedd4 deficient cells interpret TCR (αCD3/αCD28) stimulus 
differently than Nedd4 sufficient cells, namely as of lower intensity and this triggers 
only lower activation and IL2 production. Similar result was observed by Yang et. al  
[182] using peripheral CD4+ T cells and we could confirm this also for the CD4SP 
thymocytes. 
 
Nedd4 and TGFβ signaling 
 
From the research of protein database of European Bioinformatics Institute 
(http://www.ebi.ac.uk/pdbe/), we identified a Nedd4-like molecule  (Nedd4L) with 
65.4 % similarity with Nedd4 at the protein level. Nedd4L was described to terminate 
TGFβ-induced signaling by ubiquitination and degradation of Smad2/3 [225]. Due to 
the similar ubiquitin ligase properties of these two molecules, we examined the 
involvement of Nedd4 in TGFβ signaling. The assay was set up to examine the 
TGFβ signals in the context of the polarization capacity of naive cells in a Treg / 
Th17 in vitro polarization assay [225]. Therefore, we stimulated naive T cells from 
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both Nedd4 deficient and sufficient genotypes in culture under polarizing conditions. 
However, we observed that deficient cells maintain their plasticity within the range of 
different TGFβ concentrations and perform once again, as similar as sufficient 
counterparts (Fig. 28), reaching very similar frequencies of polarized cells at all 
different cytokine concentrations.  
 
 
A 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
Fig. 28: iTreg and Th17 polarization experiments. A – Assesment of propensity of Nedd4 deficient 
and sufficient CD4 SP thymocytes to enter iTreg lineage in the presence of TCR stimulus and TGFβ 
over a range of concentrations between 0 and 10 ng/ml. B - Polarization toward Th17 vs iTreg in the 
presence of IL6 over a range of TGFβ accompanied with TCR stimulus. The numbers in the plots 
present means of two wells per condition. 
 
Summary of the analyses in the conditional deletion of Nedd4 
 
In summary, we employed the model of conditional deletion of Nedd4 at different 
stages of T cell life and were unable to demonstrate any major differences in T cell 
phenotype and functionality over the range of maturation stages, processes and 
functional assays. We therefore conclude that Nedd4 is not playing any central role 
in T cell development, education in the thymus and performance in the periphery. 
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Nevertheless, as some intrinsic cell defects become prominent primarily in a 
competitive environment between deficient and sufficient cells [184], we assessed 
the performance of Nedd4 deficient cells in the mixed bone marrow chimera setup.  
Analysis of Nedd4 deficient mixed bone marrow chimeras 
 
The experimental setup of the mixed bone marrow chimeras was to generate a 
mixture of equal composition between Nedd4 sufficient (CRE x Nedd4+/+) and 
deficient (CRE x Nedd4fl/fl) bone marrow. This system assesses the performance of 
both cell types in parallel at every stage and in every process. 
 
The bone marrow composition was assessed by examining the presence of CD45.1+ 
Nedd4 sufficient and CD45.1- (CD45.2+) Nedd4 deficient cells in the hematopoietic 
stem cells, common lymphoid progenitors and in lineage positive cells (Fig. 29.). For 
the measurements within these compartments we used Vav-CRE deleter, to secure 
ablation of Nedd4 at the very early time point. The assessed populations showed 
mainly equal ratios in the presence of both cell types and therefore provided a basis 
for further experiments. The total bone marrow was composed almost equal 
amounts of Nedd4 deficient and Nedd4 sufficient cells. The ratios were consistent 
within Lin-c-KIT+ population (enriched for hematopoietic stem cells) with 48.6 ± 5.9 % 
of deficient and 51.9 ± 5.9 % sufficient cells (p=0.648). Further, all lineage-defined 
cells in the bone marrow represented 47.4 ± 6.9 % of deficient and 52.6 ± 4.9 % 
sufficient cells (p=0.462). In addition, the specification to the lymphoid lineage is not 
affected by Nedd4 ablation as the composition of common lymphoid progenitor cells 
(Lin-c-KITintCD127+) also mirrors ratios from the total bone marrow with 51.2 ± 1.7 % 
of WT cells versus 48.8 ± 1.7 % cKO cells (p=0.338). 
 
 
 
 
 
 
 
 
                                                                                                                           Results                                                                                                                                                                                         
 
85 
 
 A 
 
 
 
 
 
 B 
 
 
 
Fig. 29: Analysis of total bone marrow in Vav-CRE mixed bone marrow chimeras. A – The 
chimerism in total bone marrow as well as in lineage positive cells and hematopoietic precursor cells. 
B – The chimerism of common lymphoid progenitors (CLP) (n=10 and n=4 for CLP staining).   
 
Composition of thymic compartments in the mixed bone marrow chimeras 
 
In the thymus of Vav-CRE Nedd4+/+ and Vav-CRE Nedd4fl/fl chimeras, we observed 
some differences in the composition of the thymocyte subsets by measuring the 
contribution of each genotype to the total chimerism. The DN1 compartment 
containing the early thymic progenitors was equally composed of both genotypes 
with 53.6 ± 8.9 % Nedd4 deficient and 46.3 ± 8.9% sufficient cells (p=0.585), 
however further stages of double negative compartment, DN2 to DN4 showed 
smaller population of Nedd4 deficient cells with the contribution dropping between 
16.7 ± 3.6 % in DN2, to 20.2 ± 5.9 % in DN3 and further to 29.4 ± 16.1 % in DN4 
(Fig. 30). These compartments were filled by Nedd4 sufficient cells, with 83.2 ± 3.7 
% (p<0.0001) in DN2, 79.8 ± 5.9  (p=0.0004) in DN3 and 70.6 ± 16.5 % (p=0.121) in 
DN4. We assumed that at this stage cells go through changes in which Nedd4 may 
play a role and therefore deficient cells experience a disadvantage, measurable by 
their chimerism contribution. This observation is supported by the evidence that in 
the chimeras using CD4-CRE instead of Vav-CRE, showed no differences in the 
contribution to the double negative compartment (Fig. 32).   
Further in the thymocyte development, the chimerism ratios equalized to the starting 
≈50:50 ratio, suggesting that the deficient cells have an advantage at the preceding 
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selection steps. At the DP stage deficient cells contributed more than in the DN 
compartment with 36.9 ± 12 % versus 63.1 ±12.5 % of sufficient cells (p=0.194) and 
by the SP stage these cells reached the equal contribution as the sufficient cells with 
56.4 ± 9.2 % (p=0.361) in CD4 SP and 57.8 ± 6.5 % (p=0.137) in CD8 SP (Fig. 30). 
The thymic Treg population was composed of 63.8 ± 3.9 % deficient and 36.1 ± 3.9 
% sufficient cells (p<0.0001), which indicates that although the total CD4 SP stage 
comprises equally of both genotypes, Treg compartment seems to be preferentially 
filled by Nedd4 deficient cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 30: Composition of thymic subpopulations in mixed bone marrow chimeras. A - Thymocyte 
subpopulations of Vav-CRE mixed bone marrow chimeras segregated by CD4 and CD8 staining. 
Histograms show CD45.1 expression of different thymocyte subsets and numbers indicate means ± 
s.d. of frequencies within the gates.  B - Diagram presents means ± s.d. of chimerism contribution for 
Vav-CRE x Nedd4+/+ (black squares) and Vav-CRE x Nedd4fl/fl (red triangles).  
 
 
                                                                                                                           Results                                                                                                                                                                                         
 
87 
Disadvantages and the DN2/3 stage and the γδ T cell lineage contribution  
 
At the stage of DN2/3, one of the major decisions, apart from T cell lineage 
commitment is the αβ versus γδ lineage decision. Therefore, we were interested 
whether Nedd4 impacts this process. Despite the fact that we were unable to 
observe any change in γδ T cell frequencies in our first set of analysis, in the mixed 
bone marrow chimeras, Nedd4 deficient cells contributed slightly but significantly 
more to the γδ lineage than the sufficient cells did, with 0.192 ± 0.01 % compared to 
0.127 ± 0.01 % (p=0.0018).  
 
 
 
 
 
 
 
 
Fig. 31: Contribution to the γδ T cell lineage. The panel shows higher contribution of Nedd4 
deficient T cells to the γδ T cell lineage. Plot presents staining gated on whole thymocytes. 
 
If one would assume that the preTCR and TCR signaling pathways utilize the same 
downstream molecules, this observation might be explained by the fact that the 
Nedd4 deficient cells interpret preTCR at the β selection stage as of lower strength 
and therefore preferentially enter the γδ T cell lineage. This hypothetical scenario 
provides just one possibility to explain the observed differences, as the role of signal 
strength of preTCR in the lineage commitment is still controversial. Nevertheless, we 
evidenced the higher propensity toward  the γδ lineage in the absence of Nedd4.  
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Nedd4 deficiency promotes entry into Treg lineage 
 
In the analysis of CD4 SP compartment of mixed bone marrow chimera, utilizing 
CD4 CRE deleter a difference between the contribution of deficient and sufficient 
cells was evident at the CD4+CD25+Foxp3+ level. The thymic Treg pool consisted of 
68.78 ± 3.2 % Nedd4 deficient cells and 30.06 ± 4.0 % (p<0.0001) sufficient ones. 
The CD25+Foxp3- as well as CD4 SP stage in general was not affected and 
consisted of both genotypes equally (Fig. 32). This segregation was evident also in 
the peripheral lymphoid organs (Fig. 33).  
 
A 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
Fig. 32: Thymic Treg compartment in the mixed bone marrow chimera. A – The plots present 
chimerism between CD4 CRE Nedd4+/+ (CD45.1+) and CD4 CRE Nedd4fl/fl (CD45.1-) cells in the 
major thymic compartments, including CD25+Foxp3- and CD25+Foxp3+ populations. B – Diagrams 
present frequencies measured in each sample.  
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Fig. 33: Contribution of Nedd4 deficient cells to the CD25+Foxp3+ CD4 T cells in the peripheral 
lymphoid organs. Panel represents data for the spleen, pooled lymph nodes and the mesenteric 
lymph nodes  
 
 
In sum, we analyzed the composition of the cellular compartments in the Vav-CRE 
and CD4-CRE Nedd4 deficient models and were able to show that Nedd4 has roles 
in the DN2/3 stage and potentially the γδ lineage commitment. Further, we 
evidenced the advantage of Nedd4 deficiency in the propensity toward Treg lineage, 
compared to the Nedd4 sufficient counterparts. 
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Next, we extended our analysis to the periphery and examined the activation status 
of peripheral CD4 T cells. In the spleen as well as in the pooled lymph nodes, some 
minor difference in frequency of naive and activated / memory cells was evident (Fig. 
34). The Nedd4 deficient compartment contained more naïve; 77.1 ± 3.1 % versus 
65. 8 ±3.6 (p=0.046) and tendentially less activated cells; 14.1 ± 2.6 % versus 22.6 ± 
2.5 % (p=0.061), which is in line with the publication of Yang et. al [182] and the idea 
of the T cell hyporesponsiveness due to the Nedd4 deficiency. This result is however 
evident only at the 16 weeks post reconstitution. At the earlier time points the 
differences are not so prominent and do not reach significance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 34: Activation status of CD4 T cells in the CD4 CRE mixed bone marrow chimeras. As 
depicted CD4 cells were distinguished for CD45.1 Nedd4 sufficient and CD45.2 Nedd4 deficient T 
cells. Further, the segregation of these cells in CD62L and CD44 was examined and diagrams show 
the frequencies of naïve and memory CD4 T cell population within each genotype. 
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To additionally support the hypothesis that Nedd4 deficient T cells are intrinsically 
hyporesponsive and show defects in TCR signal regulation and adaptation we 
transferred mixtures of equal numbers of deficient and sufficient cells into Rag1-/- 
animals and assessed the degree of activation 5 days upon injection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 35: Adoptive transfer of mixed CD4 T cells from CD4 CRE Nedd4+/+ (CD45.1+) and CD4 CRE 
Nedd4fl/fl (CD45.1-) into Rag-/- animals. Transferred cells were gated on CD4 and distinguished by 
expression of CD45.1. The expression of TCRβ, CD5 and CD25 was determined on each population. 
Mean of frequencies for examined parameters ± s.d. are depicted in the diagrams. 
 
The Nedd4 deficient cells did not downregulate their TCRβ as highly as sufficient 
cells. 11.49 ± 0.5 % Nedd4 deficient cells compared to 0.73 ± 0.2 % (p<0.0001) kept 
their TCR expression upon transfer and likely TCR stimulation. The CD5 expression, 
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directly correlating to the TCR signal a cell has received [226], was significantly 
lower in deficient cells with 28.67 ± 2.3 % compared to 47.5 ± 2.9 % (p<0.0001) in 
sufficient population. The amount of CD25 on the surface was similar between the 
two groups.  
Therefore, we concluded that Nedd4 deficient cells are intrinsically hyporesponsive 
and do not depend on extrinsic signals of other CD4 T cells nor any surrounding.  
 
Nedd4 and the superantigen-induced negative selection 
 
Finally, if we hypothesize that the absence of Nedd4 rescues T cell from the negative 
selection and instructs it into the Treg lineage, the strong TCR signals would be 
interpreted as of lower strength. One of the possibilities to test this is the 
superantigen mediated selection [227]. We therefore generated F1 animals between 
the BL/6 and BALB/c mice as donors of one part for the mixed bone marrow chimera 
to introduce the I-E molecule, needed for the superantigen recognition. We 
postulated that the Nedd4 deficient CD4 SP compartment shows enrichment for 
SAg-specific Vβ chains (Vβ3, 5.1, 6, 11 and 12) and that T cells bearing these chains 
show enriched Foxp3 expression. We evidenced equal deletion of specific Vβ chains 
between the two genotypes (Fig. 36) and similar contributions of Nedd4 deficient and 
sufficient cells in the Foxp3+ compartment (Fig. 37). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 36. Superantigen mediated deletion. Bar diagram presents the frequency of Vβ chains in the 
BL/6 mixed bone marrow chimera (black - Vav-CRE Nedd4+/+, red - Vav-CRE Nedd4fl/fl) and in the F1 
setting (gray – F1 Vav-CRE Nedd4+/+, light red - Vav-CRE Nedd4fl/fl). 
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Fig 37. Foxp3 populations in the deleted Vβ  specificities. The plots present frequency of the SAg-
deleted Vβ species in the CD4 compartment. Further, the contribution of the each genotype to the 
Treg compartment of each Vβ population is depicted.  
 
The observation from this experiment indicate that the process of SAg-mediated 
deletion is not affected by the deficiency of Nedd4 and that the Nedd4 plays 
potentially a minor role impacting only the TCR fine tuning.  
 
Taken together, we showed that Nedd4 deficient cells are intrinsically 
hyporesponsive, produce less IL2 and proliferate less compared to the wild type 
cells. In the competitive situations Nedd4 deficient cells have higher propensity to 
enter γδ and Treg lineages. The data collected during this project and presented 
here forms a basis for a study of the Nedd4’s TCR fine tuning properties in the 
negative selection versus Treg deviation that is certainly to be examined in the 
single-specificity TCR / cognate-antigen models.  
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DISCUSSION 
Gene expression profile of CD4 SP thymocytes as basis  
 
The data obtained through microarray analysis indicated that the three analyzed 
populations SP1, 2 and 3 are very similar to each other and suggest the differences 
in maturation, plasticity and developmental status results from only small number of 
differentially expressed genes. In the search for the molecules that might be the 
basis for these developmental differences, we focused on two candidates – Lztfl1 
and Nedd4. Lztfl1 had no reported involvement in the immune system, while Nedd4 
was already reported to be involved in TCR signaling in the periphery. From that 
perspective, we had one candidate with completely unknown functions and one 
candidate which functions we applied to the thymic T cell development. What one 
can conclude from the overall microarray analysis result is that the examined CD4 
SP stages do not exceptionally differ between each other. The directionality of 
observed changes in the gene expressions adds to the previous work of Jin et al., 
that SP 1, 2 and 3 stages represent continual and consecutive developmental points 
of the total CD4 compartment and that regulation of expression for each gene has 
already taken its direction. Apart from this conclusion and in the relationship to the 
work performed by Wirnsberger et al. it becomes obvious that the propensity toward 
Treg development and possibly many other decisions does not need major changes 
in the gene expression. These observations support the notion that cell fate 
dependens on several issues but definitely minor changes in the expression of some 
intrinsic factors add to that. Lastly, the palette of differentially expressed genes 
included not only molecules from the TCR signaling but also targets like cytokine-
inducible proteins, nucleoside metabolism regulators and cell cycle players. 
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Lztfl1 – Ciliary transport, immunological synapse and T cell fate 
 
Leucine zipper transcription factor - like 1 is downregulated with the maturation in 
CD4 SP cells and was selected as one of the candidates. 
In the initial screen, we showed that overexpression of Lztfl1 at the CD4 SP stage 
prevented the developing thymocytes to enter regulatory T cell pool. Besides from 
this, we were unable to describe any other difference in the T cell system due to 
Lztfl1 overexpression or partial knockdown. Therefore, this is the first and only 
evidence that Lztfl1 has any implications in the T cell biology.  
 
To date, Lztfl1 has been mainly described in the context of the ciliary molecular 
transport machinery, BBSome, as previously mentioned and the human orthologue 
was recently renamed to BBS17 (Ensemble June 2013). Although the idea of ciliary 
system in the immune system and particularly in T cells has almost no appreciation, 
we identified some potential similarities between current knowledge of BBSome 
biology and the immune system.  
 
The BBSome is a protein complex involved in the ciliogenesis [228]. Primary cilia are 
cellular projections or microtubule-based organells that emerge from the surface of 
almost all cells. The first connection of BBSome to the cilia biogenesis was based on 
the observation that bbs mutated C.elegans has shorter sensory cilia. Further work 
showed that the BBSome is present in the cilia and its subunits are conserved 
throughout all ciliated organisms [213, 229-231]. BBSome is a complex of seven 
core proteins that have been initially discovered in patients with Bardet Biedl 
syndrome. This syndrom is a genetic ciliary defect characterized by a combination of 
severe developmental abnormalities, like polydactyly, retinal degeneration, renal 
abnormalities, hypogenitalism and obesity [232].  
 
BBSome is required for functionality of cilia by stabilizing intraflagellar trafficking 
(IFT) proteins complexes (Fig. 38). IFT particles are composed of multiple IFT 
molecules that in turn transport newly produced proteins in the anterograde direction 
from the Golgi apparatus to the tip of the cilium and in the retrograde direction from 
the cell membrane, as the part of the recycling process back for the degradation. 
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This transport with all its players, BBS and IFT proteins is central to communication 
and sensing of the surrounding to the cell [233].  
 
 
 
 
Fig.38: Scheme of ciliary transport involving IFT and BBS molecules and counterpart of this 
process in the context of immunological synapse. (Adapted from Finetti et al. Trends in 
Immunology 2011) 
 
 
The current position of Lztfl1 as the negative regulator of BBSome recruitment to the 
ciliary membrane is based on the work of Seo et al..  Here, Lztfl1 has been found to 
interact with BBSome subunit Bbs9 and inhibits ciliar entry of the BBSome, 
scattering it in the cytoplasm away from usual position near centrosomes and ciliary 
base. The assembly of BBSome did not seem to be impaired by lack or 
overexpression of Lztfl1 in this work, but ablation of Lztfl1 lead to increased levels of 
Smo protein in the ciliary membrane [172].  
In order to merge this observation with our interest in the Lztfl1’s roles in the immune 
system, we broadened the idea that cilium, although not observed in the 
lymphocytes, might have a pendant in the immunological synapse. There are some 
important similarities between the cilium and the immunological synapse. Firstly, 
both can serve as a place of exchange and communication between two cells. 
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Secondly, the centriole and Golgi apparatus are placed in the proximity of both 
structures and can provide needed material [234]. Additional insight in the 
importance of IFT molecules was provided by work of Finetti et al., who showed that 
IFT20 was essential for sustained TCR signaling, as knockdown of IFT20 resulted in 
impaired tyrosin phosphorylation and impaired TCR activation. Upon TCR 
stimulation, IFT20 has been shown to interact with IFT57 and IFT88 in addition to 
direct TCR binding and so initiates the TCR recruitment to the synapse [235]. 
Whether these IFT molecules interact with BBSome in T cells is still unknown.  
 
One possible postulation is that IFT complexes need to form and assemble with 
BBSome for the transport of TCR and accessory molecules to the immune synapse 
to initiate the signaling and secondly, it might be that IFT/BBSome mechanism is 
important in ceasing the signal via retracting TCR molecules from the membrane. 
If we assume that Lztfl1 interacts with Bbs9 in the T cells as well and therefore 
prevents accessibility of BBSome for IFT-mediated TCR transport to the membrane, 
a Lztfl1 overexpressing thymocyte would have difficulties to pass the check point of 
positive selection. In our experiments this was not the case. We observed normal 
frequencies of CD4 single positive cells in the thymus upon both selection steps. The 
fact that Treg compartment is smaller, one could explain with the scenario that Lztfl1 
overexpression keeps BBSome away from the immunological synapse and prevents 
recycling of TCR molecules, leading to higher number of TCRs available and 
potentially longer interactions. If the decision between apoptosis and Treg 
commitment is influenced by avidity of the signal and the timing, Lztfl1 could have a 
role in this aspect. According to these simple scenarios Lztfl1 mice could have 
interesting defects in TCR selection process. However, this remains to be studied. At 
present, our main goals next to the generation of the conditional knock out model are 
exploration of Lztfl1s interactome in T cells via protein co-immunoprecipitation and 
studies of its localization in context of different T cell subsets and upon T cell 
stimulation. 
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Nedd4 and TCR fine-tuning 
 
Nedd4 was one of the molecules with decreasing expression between the SP1, 2 
and 3 populations. Despite the difficulties in the initial screen by gain-of-function 
experiments and with the advantage of the availability of conditional knockout model, 
we explored the roles of Nedd4 in the T cell biology. In the immunologically relevant 
literature, Nedd4 has been described to target Cbl-b for ubiquitination and so 
promotes T cell activation [182] (Fig. 39.).  In contrast to the Cbl-b deficiency, 
characteristic for the spontaneous autoimmunity, Nedd4 deficiency shows less 
systemic effects. In the Cbl-b deficiency the activation of T cells proceeds in the 
absence of CD28 signaling and despite normal Treg development, mice develop 
strong autoimmunity [236, 237]. As Nedd4 is part of the TCR signaling machinery, 
but does not interfere enormously with the full T cell activation cascade, we 
considered it as a good tool to assess the importance of TCR fine-tuning in the 
thymic selection processes. 
 
 
 
 
 
 
 
Fig. 39: Nedd4 targets Cbl-b for ubiquitination and degradation. A model of Nedd4 action in T cell 
signaling, proposed by Yang et. al.. Nedd4 ubiquitinates Cbl-b and promotes its degradation by 
proteasome. The absence of Cbl-b, as one of the important inhibitory mechanisms, results in lower 
TCR threshold as prompt T cell activation. If there is an additional effect of Nedd4 on the promotion of 
TCR signal and T cell activation remains unclear. 
 
In contrast to previously published work on Nedd4, we designed a T- cell specific 
ablation of Nedd4 via four different, stage-consecutive CRE deleters, Vav-, Lck-, 
CD4- and Foxp3 - CRE. Further, we examined the performance of Nedd4 
conditionally deficient cells in direct comparison to the Nedd4 sufficient cells in the 
mixed bone marrow chimeras.  
The studies performed on the conditional deletion of Nedd4 did not reveal any 
additional differences than those already described by Yang et al., like lower 
proliferation capacity and IL2 production, as well as intrinsic hyporesponsiveness. 
+ 
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Further, thymic T cell development did not seem to be affected by the loss of Nedd4 
at any stage in these experiments. This data provided us with the information that 
the effect of Nedd4 at the TCR signaling level does not massively impact generation 
of a T cell population but most likely, this fine-tuning solely shifts the whole repertoire 
of generated T cells (Fig. 40). Therefore, newly generated T cells do not differ in their 
numbers, frequencies or phenotypical markers but probably in the affinity of their 
TCRs, compared to the theoretically possible repertoire generated in the presence of 
Nedd4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 40: Thymocyte development and fate in context of TCR affinity. In the Nedd4 sufficient cells 
(Nedd4+/+) a defined repertoire of naïve and Treg T cells is generated. In the absence of Nedd4 
(Nedd4cKO/cKO), developing thymocytes are hyporesponsive and interpret received TCR signals as of 
lower strength. This leads to the shift in the generated repertoire. 
 
In order to test this, one would have to have several defined specificities and 
compare their selection progression with or without Nedd4. With this defined 
spectrum of specificities one could ask whether certain specificities pass the 
selection steps differently in the absence of Nedd4. This might then define a 
particular TCR strength ‘window’ for which the described TCR fine-tuning by Nedd4 
might play a role. A tool that has been described by Lee et. al [238], a series of 
retrogenic TCRs with different affinities for OVA could be used to assess the impact 
of Nedd4 in the selection of each specificity and to simultaneously track the potential 
shift in the repertoire. 
                                                                                                                     Discussion 
100 
In the search for some general defects, we performed mixed bone marrow chimera 
in order to compare the fitness of deficient and sufficient cells at all levels of T cell 
life. This approach has a vast advantage to the analysis of the ‘straight’ deficiencies, 
as it applies clonal pressure to the cells and assesses their ability to compete, while 
crystalizing the differences based on the Nedd4 deficiency. Therefore, one gains 
information about the intrinsic properties of cells.   
In this experimental setup, we observed the disadvantage of Nedd4 conditionally 
deficient T cells at the double negative stage in the early thymic development. If one 
would assume that molecules accompanying TCR signaling also play a role in 
preTCR signals, Nedd4 might be of importance. In this hypothetical preTCR 
signaling, Nedd4 absence would lead to the increased Cbl-b levels and inhibition of 
signals via preTCR, meaning that Nedd4 deficient cell would be hyporesponsive at 
the stage of β selection (DN2 - 3).  As the signals provided from the newly 
rearranged Vβ chain accompanied by invariant pre-TCRα chain are the major 
parameter for the cell to assess the functionality of Vβ chain and enter the next cycle 
of rearrangements to become an αβ T cell, this hyporesponsiveness might be a 
great disadvantage.  
The options for a cell failing in the β selection are either cell death or entrance into 
the γδ T cell lineage. The work on γδ T cells development still has some debatable 
issues concerning the preTCR signal quality and strength needed to enter this 
lineage, therefore further correlations to our observations would be highly 
speculative [239-241]. It has been proposed that DN2 population independently of 
ongoing TCR rearrangements has the ability to enter one or the other lineage 
according to the signals received from the IL7 and Notch1, and that further 
expression of the TCR leads to confirmation of the decision or cell death. It has been 
shown that IL7Rαhi DN2 cells preferentially enter γδ lineage, than the IL7Rαlo 
counterparts [242]. Onward, additional factor in this precommitment is played by 
Notch1 [243, 244]. The absolute requirement for Notch1 has been shown only for αβ 
T cells, as γδ T cells can compensate effects of Notch1 via Id3, it is generally 
accepted that Notch1 is essential for proliferation and survival of cells at the DN3 
stage. Interestingly, at this point we evidenced loss of Nedd4 conditionally deficient 
cells and speculate that Nedd4 may play role in Notch1 endocytosis in developing T 
cells, as it was shown to do in D. melanogaster [245]. The loss of Nedd4 leads to 
accumulation of Notch1 on the surface due to absence of endocytosis and loss of 
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Notch1 signal. This correlation might explain the absence of DN3 cells in the Nedd4 
deficient compartment in our mixed bone marrow chimeras. We performed flow 
cytometric analysis of Notch1 expression on Nedd4 sufficient and deficient cells but 
could not evidence any differences. Additionally, CD25 as marker that correlates with 
the received Notch1 signals remained also unchanged. Nevertheless, it might be that 
Notch1 amounts or expression levels do not change with Nedd4 deficiency but that 
solely trafficking becomes affected, delayed or disturbed. 
Next observation in our experiments was that the Treg compartments are 
preferentially composed of Nedd4 deficient cells. On top of that, we observed that 
deficient cells despite their lower frequency at the double negative stage, manage to 
catch up with the sufficient cells and fill in the single positive compartments. This 
suggested that Nedd4 deficient cells cross the selection checkpoints faster than 
sufficient cells or experience some promotion at these steps. We proposed that the 
Nedd4 deficient cells interpret signals of high strength at the stage of negative 
selection as moderate due to the hyporesponsiveness and therefore escape 
apoptosis, fill up the CD4 SP compartment and become converted into Treg lineage 
preferentially (Fig. 41). The fact that the Treg pool is not enlarged argues for the 
hypothesis that there must be a selecting niche with limited capacity and potential 
saturation that does not allow boost of regulatory T cells out of all potentially 
autoreactive Nedd4 deficient T cells. This argument would also explain why we could 
not observe general increase in the regulatory population in the non-mixed situation 
of conditional knockout mice. 
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Fig. 41: Effects of differential TCR signal interpretation of the thymic selection of Nedd4 
deficient cells. At the step of positive selection Nedd4 deficient (Nedd4KO, red) cells experience 
disadvantage, as their TCR signal does not result in rescue, while at the step of negative selection 
Nedd4 deficient cells interpret strong signals as moderate and escape the negative selection, 
potentially as Tregs. 
 
This hypothetical model of Nedd4’s role in thymic selection has some overlapping 
points with the results of work of Hwang and Love, in which the attenuation of TCR 
signal (utilizing signaling deficient mutant of TCRζ chain) leads to the impaired 
negative selection and promotion of Treg development [246].  
 
In the experiment of superantigen-mediated selection we failed to show that the 
proposed model applies. The fact that this particular system of negative selection 
induces very strong TCR signals, which even overcome the need of ITAM units in 
the induction of deletion [247], argues that this negative result might not dismiss the 
whole model. Further approaches involving the TCR transgenic models and their 
cognate antigen models (like TCR-HA and Aire-HA) should be used for future 
experiments.  
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OUTLOOK 
 
In order to better understand the roles of Lztfl1 and Nedd4 in the thymocyte biology 
several open questions need to be answered in the further work.  
 
For the part related to Lztfl1, primary aim would be to generate the conditional 
knockout mouse. Secondly, the characterization of this mouse model in polyclonal or 
TCR transgenic context should add to the knowledge on Lztfl1.  
 
Other open questions, like the importance of the BBsome and the intraflagellar 
transfer (IFT) molecules in T cells can be addressed by quantitative PCR analyses of 
T cell subpopulations and further confirmed by Western blotting. In addition, the 
results generated by Seo et. al showing the interaction between Lztfl1 and Bbs4 
need to be recapitulated in T cells. For this one could generate a construct of tagged 
Lztfl1 and express it in T cell lines or over the lentiviral infections in T cells of bone 
marrow chimeras. This tag would then allow the immunoprecipitation of Lztfl1 and its 
interaction partners. 
 
Next, for the part of Nedd4 analyses, major task would be to investigate available 
TCR transgenic models and their selection in the presence of a cognate antigen on 
the Nedd4 sufficient and deficient background. Further, one could investigate if 
Nedd4 utilizes the same mechanism of TCR fine tuning over Cbl-b ubiquitination in 
the thymocytes as well as in the mature T cells. In consideration of the high Nedd4 
expression in the double negative compartment, one could investigate the roles of 
Nedd4 in the Notch transport and signaling, as some data on this has been 
generated in D. melanogaster.  
 
In sum, for both candidates several open questions remain. Nevertheless, the tools 
for the investigation of these questions are generally available and some answers 
could soon complement our knowledge on these molecules.   
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